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The use of a polymeric gel as male contraceptive, injected into the vas deferens of the 
male, has attracted a considerable amount of interest due to improved criteria over the 
current available options. The non-invasive character of these gels offer reduced side 
effects and improved reversibility over a vasectomy, rendering a promising new 
alternative to satisfy society’s ever increasing demand for an ideal contraceptive.  
This thesis focuses on the design, synthesis and characterisation of a polymer hydrogel 
system with improved biocompatibility and reversibility properties for contraception 
purposes in the male. Poly(styrene-co-maleic anhydride) (SMA), a biocompatible, 
commercially available copolymer that easily undergoes chemical modification through 
its highly reactive maleic anhydride residues is a candidate system for use in these 
hydrogel matrices. RAFT (reversible addition fragmentation chain transfer) mediated 
polymerisation was utilised for the synthesis of well-defined SMA, followed by two post-
polymerisation modification approaches. The first, prepared through modification of the 
anhydride residues in the SMA backbone and the alternative, through chain end 
modification of the thiocarbonyl thio group of the RAFT-made SMA. Preference was 
given to the first approach during the present study, as side-reactions turned out to hamper 
the disulphide formation of thiol terminal-SMA.    
Water-soluble boronic acid functionalised polymers (SMI-BA) were prepared by partial 
modification of the reactive maleic anhydride residues in SMA with 3-
aminophenylboronic acid (BA). SMI-BA was combined with poly(vinyl alcohol) (PVA) 
to prepare the required hydrogels. Gelation is achieved within minutes after mixing of 
aqueous solutions of SMI-BA and PVA, based on reversible ester crosslink formation 
between the boronic acid groups in SMI-BA and the 1,3 diols in PVA. The structural 
properties of the gels were characterized by oscillatory rheometry as a function of 
composition and degree of modification (SMI-BA). Adequate gelation times of 
approximately 1-5 minutes (37 C, PBS, pH = 7.4), with storage moduli (G’) of 12 kPa – 
50 kPa were obtained. Rapid reversibility of the gels is achieved within a few minutes by 
the addition of glucose in combination with sodium bicarbonate (NaHCO3). The results 
indicate that the polymeric hydrogel is a promising candidate for further investigation as 
an injectable gel for male contraception purposes.  




Die gebruik van 'n polimeriese jel as manlike voorbehoedmiddel deur inspuiting in die vas 
deferens buis van die man het aansienlike belangstelling gelok as gevolg van verbeterde 
kriteria oor huidige beskikbare opsies. Die nie-indringende karakter van hierdie jels bied 
verminderde newe-effekte en verbeterde omkeerbaarheid oor 'n vasektomie, wat as 
belowende nuwe alternatief kan dien vir die samelewing se toenemende vraag na 'n ideale 
voorbehoedmiddel. 
Hierdie tesis fokus op die ontwerp, sintese en karakterisering van 'n polimeer jel sisteem 
met verbeterde biologiese geskiktheid en omkeerbaarheid vir voorbehoeding doeleindes in 
die manlike geslag. Poli(stireen-ko-maleïne anhidried) (SMA), 'n kommersieel beskikbare 
kopolimeer wat maklik chemiese modifikasie ondergaan deur middel van sy hoogs 
reaktiewe maleïne anhidried groepe dien as goeie kandidaat vir hierdie jel matriks 
doeleindes. RAFT bemiddelde polimerisasie is aangewend vir die sintese van goed 
gedefinieerde SMA, gevolg deur twee sekondere polimerisasie benaderings. Die eerste, 
voorberei deur modifikasie van die anhidried groepe in die SMA ruggraat en die 
alternatief deur modifikasie van die tiokarboniel tio groep van die SMA polimeer. 
Voorkeur is gegee aan die eerste benadering tydens die huidige studie, as gevolg van 
newe-reaksies wat die disulfied formasie belemmer na die sintese van tiol terminale SMA. 
Water-oplosbare boroniese suur getransformeerde polimere (SMI-BA) is voorberei deur 
die gedeeltelike modifikasie van die reaktiewe maleïne anhidried reste in SMA met 3-
amienfenielboroniese suur (BA). SMI-BA is gekombineer met poli(vinielalkohol) (PVA) 
om die vereiste jels te vorm. Jel formasie is binne minute na die toevoeging van water 
oplosbare SMI-BA en PVA bereik. Netwerk formasie is gebaseer op omkeerbare ester 
binding formasie tussen die suur groepe in SMI-BA en die 1,3 diol in PVA. Die 
strukturele eienskappe van die jels is gekenmerk deur ossillasie reologie as 'n funksie van 
samestelling en graad van verandering (SMI-BA). Voldoende jel formasie van ongeveer 
1-5 minute (37 C, PBS, pH = 7.4), met die stoor modulis (G') van 12 kPa - 50 kPa is 
verkry. Vinnige, voldoende omkeerbaarheid van die jels is binne 'n paar minute bereik 
deur die byvoeging van glukose in kombinasie met natriumbikarbonaat (NaHCO3). Die 
resultate dui daarop dat die polimeriese jel sisteem dien as belowende kandidaat vir 
verdere ondersoek as 'n inspuitbare jel vir manlike voorbehoeding doeleindes. 
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1 Chapter 1: Prologue 
 
1.1 Introduction 
Contraception is critical to health, wellbeing, development, and quality of life. Over the 
past 50 years, birth control for women has been refined to the point that there are now 
dozens of alternatives, but the lack in progress in male options has raised many concerns. 
The current state of contraceptive options is far from ideal, offering only two options i.e. 
condoms and a vasectomy. The acceptance of both these methods have been proven 
challenging due to high failure rate of condoms and the requirement of surgery, negative 
side effects and reversal issues regarded with a vasectomy.
1
 Fortunately, several other 
male contraceptive alternatives by means of hormonal, non-hormonal systemic and vas-
based methods have been under development, yet only a few are close to 
commercialisation. As such, the design of a safe, effective, reliable, reversible, non-
hormonal method for men would meet a critical need in the market.  
One promising approach, that has obtained substantial interest over the last couple of 
years, is the use of an injectable high molar mass poly(styrene-co-maleic anhydride) 
(SMA) gel combined with dimethyl sulfoxide (DMSO) in the vas deferens of the male.
2
 
The injected gel partially blocks the flow of sperm by anchoring itself to the folds of the 
inner lining of the vas deferens and has shown to reduce side effects experienced by 
vasectomised men.
3
 Reversibility of the gel by the injection of DMSO solvent, to dissolve 
the polymer to allow evacuation via the ejaculatory duct, has been successful in animals.
4
 
However, this reversal approach has required non-favourable squeezing and manipulation 
of the vas deferens. Shortcomings of the current gel include the undesired use of DMSO 
solvent during administration and insufficient reversibility, which leaves scope to improve 
the current hydrogel system. 
The design of an enhanced biocompatible hydrogel system to minimise reversal issues can 
be achieved by injection of two polymeric aqueous solutions to gel in situ in the male vas 
deferens. Chemical crosslinking of low molar mass SMA segments under physiological 
conditions, readily reversed with exposure to non-harmful additives, will provide an 
improved alternative of the above system.  
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Chemical crosslinking is a highly resourceful method for the formation of hydrogels that 
allow easy control over structural parameters to optimise synthesised gels with desired 
physical and mechanical properties.
5
 These injectable systems will have several 
advantages over the current system by means of an optimised elastic system with 
improved biocompatibility and easy reversal. 
1.2 The aim and objectives of this work  
The aim of this study was to synthesise an injectable biocompatible hydrogel for the use 
as reversible male contraceptive. This injectable gel should consist of polymers that will 
gel at physiological conditions in the male vas deferens.  
The main objectives of the study can be summarised as follows: 
1. To synthesise the SMA copolymer by a reversible-deactivation radical 
polymerisation (RDRP) technique i.e. RAFT polymerisation. 
2. To modify SMA via two post-polymerisation techniques by (1) introduction of a 
boronic acid moiety via the maleic anhydride residues in the SMA backbone or (2) 
through chain end modification of the thiocarbonyl thio group of the RAFT-made 
SMA to dimerise low molar mass SMA chains into linear high molar mass 
polymer chains suitable for hydrogel formation. 
3. To form a suitable biocompatible gel with the following requirements: (1) quick, 
effective gelation under physiological conditions (37 C, pH = 7.4) (2) easy, quick 
reversibility with the addition of non-harmful additives. 
4. To investigate the structural properties of the gels by means of swelling studies 












Stellenbosch University  https://scholar.sun.ac.za
Chapter 1: Prologue 
3 
1.3 Thesis layout 
Chapter 1- Prologue 
Chapter 1 gives a brief insight into the male contraceptive market with the introduction of 
potential injectable polymers as reversible male contraceptive. In addition, the aim and 
objectives of the study are presented. 
Chapter 2 – Historical Background 
A comprehensive literature review of the current and future developments in the male 
contraception market is presented. In addition, the disadvantages and benefits of current 
contraception methods are compared.  Furthermore, the proposed alternative of polymeric 
gels as male contraceptive is presented. 
Chapter 3 - Synthesis and Characterisation of SMA 
Chapter 3 introduces RAFT mediated polymerisation as an effective technique to 
synthesise and modify polymers for biological applications. In addition, the polymer of 
choice and the methods employed to synthesise, modify and characterise all relevant 
polymers are discussed.  
Chapter 4 – Dimerisation Model Study of SMA 
Chapter 4 represents a model study into the ineffective disulphide formation of SMA 
polymers synthesised in Chapter 3. An alternative method is developed to achieve 
disulphide formation of SMA. In addition, characterisation of the polymers is discussed.  
Chapter 5 – Hydrogel Synthesis and Characterisation 
Chapter 5 is dedicated to the formation and characterisation of gels of the polymers 
synthesised in Chapter 3. Gel formation, swelling studies, rheology and reversibility of the 
gels are described.  
Chapter 6 - Epilogue 
Chapter 6 describes conclusions and recommendations for future work. 
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2 Chapter 2: Historical Background 
 
2.1 Introduction 
Family planning is essential to the reproductive health and quality of life for families and 
communities. It is achieved through controlled use of contraceptives, allowing couples to 
manage their fertility, improving health and securing economic wellbeing. Furthermore, 
family planning by means of contraceptives prevents unintended pregnancies and ultimately 
results in the reduction of infant mortality and unsafe abortion, precluding many tragic deaths 
annually.  
Over the last few decades, significant scientific development in contraception methods for 
women has led to a substantial expansion of commercially available contraception products 
and procedures. This contraceptive revolution has allowed couples to better plan their 
families, reducing unintended and unwanted pregnancies. To date, contraception variety for 
women has been refined to the point that there are dozens of effective options available. The 




In contrast, modern contraceptive methods for men remain limited. Currently, two main 
options are available to men, i.e. condoms and vasectomy, neither being reversible or 
hormonal methods. In addition, the disadvantages of these two common birth control 
methods are quite significant. Condoms, which are not covered by medical insurance, have a 
high failure rate and vasectomies are not readily reversible. This lack of contraception 
options for men has raised many concerns and has led to numerous research attempts. A 
number of promising male contraceptive methods are currently in research stages, due to the 
ever increasing demand and need for male birth control options, despite the challenges 
associated with their development caused by economic strains and socio-political factors.
2
 
Importantly, for a contraceptive to be accepted by society it must be long term, reliable, safe, 
reversible and have minimal side effects on the body. A non-surgical, non-occlusive, non-
hormonal method with easy reversibility and minimal side effects is therefore desired. Both 
current methods and the majority of other researched methods for male contraception fall 
short of these criteria and for decades now no new method has reached the market.  
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However, in the male, the vas deferens has been shown to be a suitable site for contraception 
intervention, controlling unintentional pregnancy.
3
 Therefore, numerous attempts to create an 
ideal vas-based male contraceptive have been investigated over the last few years, showing 
improved results over systemic researched methods. In order to design an ideal vas based 
contraceptive, careful design needs to be implemented to ensure a reversible method suitable 
for long-term contraception. 
2.2 Male contraception methods currently available 
The existing male contraception situation represents a massive global concern. Over the past 
decade, pharmaceutical industries have abandoned financial interest in the field due to fear of 
disrupting the lucrative oral contraceptive market. These obstacles have led to financial 
shortcomings and long developing periods of new potential methods. Despite economic and 
political obstacles hindering development in the field, the primary problem remains the 
current state of male contraceptive technologies. Methods on the market are far from ideal 
due to inherent shortcomings relative to society’s needs. The following section will introduce 
the two current male contraceptives commercially available and present the benefits and 
limitations of both. 
2.2.1 Condoms 
Condoms, if used consistently and correctly, provide an effective method of contraception. 
They are low-cost and prevent the spread of sexually transmitted diseases, such as AIDS, 
during sexual interaction.
4
 However, they have a few main drawbacks. Condoms have 
marginal contraceptive efficacy due to improper use. One significant drawback is their poor 
long-term compliance, especially in long-term monogamous couples. In addition, men dislike 
them as they reduce sensation, hampering consistent use. In conventional rather than correct 
use, the annual pregnancy rate can be up to fifteen percent. Even when used correctly, 
breakage and slippage occur in 2% - 8% of cases.
5
 According to a new study, irregular or no 
condom use occurred in 33% of 4014 couples in casual relationships and 14% in 2387 serious 
relationships.
6
 Furthermore, allergic reactions experienced by some men and women, make 
them undesired.
7,8
 Condoms play a vital role in disease prevention and the contraceptive 
market, however, they alone cannot meet everybody’s needs. 
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Vasectomy is a well-established surgical form of male contraception where the vas deferens 
is cut, tied and the tubes are sealed to prevent sperm from entering the seminal fluid. In 
addition, pregnancy cannot occur since the sperm is blocked and absorbed by the body 
instead of being ejaculated with the seminal fluid. The first case of human vasectomy was 
reported by Ochner, a United States surgeon, in 1897.
9
 Ochner introduced and advocated 
vasectomy as a method to hinder undesirables such as criminals, perverts and paupers from 
procreating.
9
 One of the earliest practitioners of vasectomy in the 1900s, Harry C. Sharp, 
reported that he performed the procedure on inmates in an attempt to reduce criminal 
behaviour and prevent criminal reproducibility.
10
 
In recent years, the option of a no-scalpel vasectomy (NSV) technique, that takes up to 15 
minutes is now widely available.
11
 The procedure is considered simple, safe and convenient, 
however not immediately effective due to the remainder of sperm present beyond the now-
blocked tubes.
12
 After surgery, other birth control methods need to be implemented for about 
3 months to ensure no more sperm is present in the seminal fluid.   
The procedure is considered permanent and beside high costs, success in the reversal of this 
procedure is minimal. A vasovasostomy, vasectomy reversal, is a delicate microsurgical 
procedure, and success thereof is greatly dependant on the surgeon’s skill.
13
 The reversal 
success is also dependent on the number of years between vasectomy and vasovasostomy.
14
 It 
has been reported that pregnancy success rates are as low as 30%, especially in cases when 
men have had their vasectomy for many years.
15
 Results show that approximately 6% of 
vasectomised males will eventually seek reversal surgery.
16
 
Despite low reversal success being dependant on the surgery itself, the major drawback of the 
process is the development of antisperm antibodies caused by the continuation of sperm 
production by the male after a vasectomy. The body responds by absorbing most fluid 
through the membranes and solid content gets broken down by responding macrophages and 
reabsorbed through the blood stream. However, sperm maturation takes place in the 
epididymis over a period of 30 days before leaving the testis and over time the membranes 
have to increase in size to accommodate the capacity of the fluid. As a result, an increased 
number of macrophages are recruited to destroy the sperm build-up. The disadvantage of this 
is that the body will persist to develop these antibodies even after the vas deferens tubes are 
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Long term complications of a vasectomy procedure include chronic pain conditions, post-
vasectomy pain syndrome (PVPS), which affects 15% -33% of patients either immediately or 
years after surgery.
18
 Postulated etiologies for PVPS include: Epididymal congestion, nerve 
damage/entrapment, fibrosis from the body's reaction or surgical wounds or sperm 
granulomas caused by sperm leaking from the severed duct.
19
 All of the above complications, 
a direct result of complete severing of the duct during surgery, can effectively be minimised 
by the use of a method which intends to keep most of the vas deferens intact either by smaller 
incision or puncture. 
Even with recent improvements of existing methods, the increased demand to develop a new 
method remains since no current method matches the criteria for an ideal contraceptive. This 
deficiency of current methods to meet the needs of men leads to disapproval and rejection, 
resulting in lack of family planning. As pointed out earlier, this can have quite a significant 
effect of economic wellbeing.  
2.3 Need for new male contraceptives 
The current male contraceptive situation is far from ideal. To date, an acceptable, reliable, 
reversible male contraceptive remains elusive. Currently available methods, condoms and 
vasectomy, don’t meet everyone's needs and the continuously increasing abortion rates raises 
big concerns. In light of this, studies since 1998 show that males seek access to improved 
contraceptives in order to share the responsibility for contraceptive measures.
20
 The studies 
indicate that over 60% of men in Germany, Brazil, Mexico and Spain are amenable to use a 
new method of male contraception.
20
 In an additional study conducted under British men, 
80% picked the idea for a male contraceptive pill as one of their top three choices.
21
 Thus, the 
time is ripe to introduce new methods to the contraceptive market in an attempt to reduce 
abortion rates and satisfy the contraceptive needs of society. 
2.3.1 High abortion rates 
In South Africa, over 80,000 registered abortions are performed annually, the majority of 
which can potentially be avoided by implementing family planning.
22
 Furthermore, 
information on teenage pregnancy indicates that 20% of girls, between the ages of 15 and 19, 
reported that they had been pregnant.
23,24  
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Risks associated with having an unintended pregnancy, whether terminated or not, on the 
maternal and perinatal health is increased, especially in unsafe termination.
25
 According to 
the WHO, unsafe abortion is one of the leading causes of maternal mortality.
26,27
 Unintended 
pregnancies are associated with poor pregnancy and child health outcomes, especially with 
closely spaced pregnancies.
28,29,30
 Unsafe abortion also results in other consequences, such as 
stigmatisation, economic costs to families and to health system providers and psychosocial 
effects on women.
 
All abortions, both safe and unsafe, are a captivating indicator of unintended pregnancy 
incidence. The application of particular attention to factors that contribute to unintended 
pregnancies and unsafe abortion is a crucial step in reducing the international health burden 
of women. The majority of unintended pregnancies can be potentially avoided with the 
implementation of family planning by use of contraceptives, which has been shown to 
decrease abortion rates. 
2.3.2 Current contraceptives don’t meet everyone’s needs 
Contraceptives are crucial to the success of family planning and new developments in 
contraceptive technologies continue to make family planning more accessible to couples 
looking to space the birth of their children.  Current contraceptives for men and women are 
falling short, and new advancements are required to meet the demands of people in 
developing countries. Furthermore, men and women have dissimilar reproductive 
requirements throughout their years, thus it is essential that they have access to a variety of 
contraceptives to help them plan, space, and restrict pregnancies. 
The current state of the contraceptive market leaves two large groups unserved. The first 
group consists of women who encounter unbearable side effects from usage of hormonal 
methods, which include breast tenderness, weight gain and diminished libido.
31
 
In addition, some modern contraceptives can be difficult to use consistently and correctly, 
while others result in severe side effects that lead to discontinued use. The second group is 
composed of young men for whom a vasectomy is not ideal and who want a more reliable 
method than the use of condoms to control fertility. 
Modern contraceptive technologies are needed to overcome these challenges and contribute 
to an unfulfilled need for family planning. New technologies should be low cost, reversible 
and widely available. Furthermore, they should have minimal or no side effects on human 
health. New products or procedures with new improved qualities could help reach a new 
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market of potential contraceptive consumers and recapture men who have abandoned use 
after discontent and frustration of current methods. In order to design such a method, careful 
consideration needs to be implemented to ensure the method will comply with a number of 
properties desired by society. 
2.1.1 The ideal male contraceptive 
The acceptability of a male contraceptive is measured by the prevalence and continuation of 
practice of a specific method. For a contraceptive method to be accepted by society it must 
satisfy a particular set of properties. Satisfaction of these properties is crucial, and would 
ultimately lead to an ideal male contraceptive.  
The ideal male contraceptive requirements: 
 Acceptability by both partners 
 Should be safe and preferably long term 
 Similarly effective as female methods with rapid onset of contraceptive action 
 Applied independent of the sexual act 
 No interference with libido or the sexual act 
 No unacceptable short and long term side effects on the body 
 Fully reversible 
Failure of the current contraception techniques is primarily due to the dissatisfaction toward 
the current techniques. The dissatisfaction of requirements has led society to demand new 
contraception methods. A number of promising methods are currently in research stages, due 
to this growing demand and need for male birth control options. In the next section, the male 
reproductive physiology will be introduced in order to understand the onset of action of 
hormonal methods, with particular attention to potential hormonal male contraception 
methods. 
2.2 Male contraception approach 
In an attempt to introduce new male contraceptives to the market, scientists have focussed 
primarily on the development of methods that inhibit spermatogenesis through the use of 
testosterone to induce negative feedback mechanisms. 
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2.2.1 Male reproductive physiology 
The male reproductive system consists of the testes and a series of ducts and glands that 
produce sperm, fluids, and hormones. The male testes, composed of twin endocrine glands, 
are the most essential organs of the male reproductive system responsible for sperm and 
testosterone production. Testosterone, a steroid hormone, is important in the maintenance of 
muscle, bone mass and libido of the male.
32
 Furthermore, testosterone has positive benefits 
on mood, cognition and general wellbeing.
33
 
An intricate feedback loop is responsible for testicular function and the production and 
regulation of hormones (Figure 2.1). The principle regulator of pituitary gonadotropins 
follicle-stimulating hormone (FSH) and luteinizing hormone (LH) secretion is gonadotropin-
releasing hormone (GnRH), a decapeptide secreted by hypothalamic neurons by part of the 
brain in a pulsatile fashion.
34
 Testosterone is produced by the gonads, Leydig cells within the 
interstitium of the testes, and its production is stimulated by LH, essential for reproduction.
35
 
Sperm cells are produced within the seminiferous tubules, where their maturation is 
supported and nurtured by Sertoli cells under the influence of FSH and high levels of 
intratesticular testosterone.36 
 
Figure 2.1 The endocrinology of spermatogenesis and male hormonal contraception.
37
 Solid arrows 
promote spermatogenesis; dashed lines indicate inhibition of spermatogenesis. 
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Based on the male physiology, the use of a male contraceptive can offer success by one of 
three main methods: (1) the use of physical barriers such as condoms or vasectomy; (2) the 
prevention of sperm production using hormonal methods; and (3) the inhibition of sperm 
functions by either sperm vaccines or polymer gel injection. A number of contraceptive 
techniques that fall into one or more of these categories are currently being developed world 
wide due to shortcomings of current methods on the market.  
They are generally divided into three categories namely: (1) hormonal systemic, (2) non-
hormonal systemic and (3) vas-based approaches. Although several of these contraceptives 
are close to commercial production, none are currently available. The majority is still at the 
stage of basic scientific research and tested in animals. Only a few systems have entered the 
process of clinical trials, while others have been abandoned due to negative outcomes. 
Examples of currently investigated hormonal methods with their benefits and shortcomings 
will be discussed in the following section. 
2.2.2 Hormonal systemic approaches 
Over the last four decades, development of hormonal targets for male contraception has been 
pursued. A male hormonal contraceptive (MHC) would be analogous to female hormonal 
contraceptive composed of a combination of various hormones that aims to suppress sperm 
production. Surveys conducted in various countries have shown that a hormonal method, 
administered by periodic injections or daily pills would be considered by a substantial 
number of men and women.
38,39
 
A hormonal systemic approach can be accomplished by stopping the secretion of male 
hormones in the brain and testes. Supraphysiological doses of testosterone have the ability to 
act as a contraceptive by suppression of the pituitary gonadotropins LH and FSH. Low levels 
of LH and FSH deprive the testis of sperm production, however not in all men. Hormonal 
contraceptives do not incapacitate existing sperm; they only stop the initiation of sperm. The 
fastest possible onset of efficacy after taking a MHC would be two to three months since it 
takes an average of 72 days for the last spermatids produced to travel through and exit the 
epididymis. Administration of unmodified testosterone (Figure 2A) is impractical because 
when given orally or by injection it is quickly degraded by the liver.
40
 Therefore, most 
hormonal contraceptive regimens have used longer-acting injectable testosterone esters. 
There are currently three major classes of MHCs which will be discussed here. 
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Androgen, a male sex hormone, can be used to block the production of natural testosterone 
by the addition of a quantity of synthetic testosterone higher than generally found in 
circulating blood (Figure 2A).
41
 Synthetic testosterone in the blood stream prevents the 
production of GnRH and LH, through the inhibition of crossing over to the testes, keeping 
testosterone in the testes too low for sperm production. An injectable testosterone ester, such 
as testosterone enanthate (TE) (Figure 2B) can be given by intramuscular injection on a 
weekly basis to achieve infertility. On such a regimen, it can be expected that sperm counts 
will approach zero after 2 to 3 months, with recovery of normal sperm totals around 3 to 4 
months after terminated injections.  
 
Figure 2.2 Androgens researched as a male contraceptive: (A) testosterone, (B) testosterone enanthate, 
(C) testosterone undecanoate, (D) 5α-methyl-19-nor-testosterone. 
Two multicentre studies of TE, conducted by the WHO, as a male hormonal contraceptive 
have shown good efficacy above 95%.
42,43
 In both trials, no major side effects were reported, 
and sperm counts returned to normal after discontinued testosterone injections. However, the 
required weekly injections are a drawback to some patients and resulted in discontinued 
involvement in the trials. In addition, a delay in full contraceptive action of 3 to 4 months is a 
deterrent. Despite the drawbacks of the current method, the studies have shown that injected 
TE is effective, safe, and fully reversible as a contraceptive in the majority of men. A portion 
of men failed to respond to the hormones and remained fertile. Studies show that an increased 
amount of TE results in the decrease of high-density lipoprotein cholesterol (HDL-C) serum, 
which could accelerate atherosclerosis, the narrowing and hardening of arteries.
44,45
 Poor 
acceptability of weekly injections resulted in the development of sustained testosterone 
delivery methods.  In addition, testosterone undecanoate (TU) (Figure 2C), results in normal 
serum T levels for at least 6 weeks in hypogonadal men.
46,47,48
 Despite attempts of two large 
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2.2.2.2 Progestin with androgen replacement 
A synthetic testosterone progestin combination hormone was shown to be successful in 
achievement of male contraception. This is attributed to the fact that synthetic progestins 
(Figure 2.3) inhibit the production of the gonadotropins FSH and LH from the pituitary, 
which results in the lack of production of spermatids and testosterone in the testes.
50
 
Synthetic testosterone acts as a replacement to maintain male characteristics. The hormone 
combination to block sperm production has extensively been tested.
51,52,53
 Injections of 
medroxyprogesterone acetate (DMPA) in combination with testosterone have had good 
success in Chinese and Australian trials.
54,55
 Drawbacks of the progestin, levonorgestrel 
(LNG), in combination with TE were weight gain and decreases in the HDL-C in comparison 
to TE alone. 
 
Figure 2.3  Progestins researched as a male contraceptive research: a) medroxyprogesterone acetate 
(DMPA), b) levonorgestrel, c) desogestrel, d) cyproterone acetate. 
 
2.2.2.3 GnRH antagonist with androgen replacement 
The addition of GnRH antagonists as adjuvant to androgen therapy has been tested as male 
contraceptive.
50
 The GnRH antagonists bind to the GnRH receptors and block the production 
of FSH and LH, necessary to produce spermatids and testosterone.
56
 However, the need for 
daily administration renders them impractical for long-term use in males. The GnRH 
antagonist, cetrorelix in combination with 19-nortestosterone have had promising results, but 
azoospermia was not maintained after discontinued treatment.
57
 Even with promising results, 
further studies to delineate the effects are crucial before it can be tested in clinical trials. 
Despite numerous attempts to develop a suitable hormone-based male contraceptive, several 
side effects and drawbacks are ever present. These drawbacks include increased acne, mood 
changes and a depressed level of HDL-C in the blood. This potentially means that men with a 
risk of heart disease should be advised to avoid MHCs.
58
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One major concern researches have to solve, before commercial availability, is the fact that 
some men don’t respond to hormonal treatment at all. This is due to the lack of knowledge 
regarding the current mechanism, thus they can’t predict which men will respond to MHC 
treatment.
58,59
 The biggest disadvantage of the abovementioned approach is the systemic 
delivery, which results in negative side effects on other parts of the body due to lack of 
targeted delivery.  
2.2.3 Non-hormonal systemic approaches 
Non-hormonal approaches of contraception include the use of compounds by targeting either 
sperm production or sperm mobility to impair or disrupt the production of spermatids. The 
selectivity, specificity and fewer side effects makes these approaches attractive candidates, as 
opposed to hormonal methods plagued by side effects. Furthermore, these methods allow 
more rapid onset of action. Over the last few decades, a variety of new methods have been 
developed, however progress has been slow, as many of these are still in research stages of 
development.  
Early stages of development include testicular targets such as local application of heat in the 
scrotal area
60,61





the use of compounds such as indenopyridines that target Leydig or Sertoli cells, crucial to 
sperm production, have also been reported.
68,69
 The oral administration of 1-(2,4-
dichlorobenzyl)-1H-indazole-3-carbohydrazide (adjudin) has been shown to disturb the 
adhesion and interaction of Sertoli cells and germ cells.
70,71,72,73
 Epididymal targets prohibit 
the maturation of spermatozoa in the epididymis.
74,75,76
 
There are currently a number of potential non-hormonal male contraceptives with different 
mechanisms being researched. Although these approaches are still far away from clinical 
introduction, they offer potential for sperm specific techniques and great promise as 
reversible, long-term contraceptives with minimal side effects.  
2.2.4 Previous Vas-based approaches 
The vas deferens, the duct that transports sperm from the testicle to the urethra, has been 
shown to be a suitable site for male contraception.
3
 Vas occlusion methods block the vas 
deferens with the aim to leave the tube intact, offering several advantages over a vasectomy 
and systemic methods. By leaving the tube intact, numerous complications experienced by 
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vasectomy patients are effectively minimized. Easy, successful reversal is achieved by simple 
removal of the device from the vas. 
The vas-based approach offers target site-specific contraceptive control over systemic 
methods, resulting in limited side effects. In this section, we will introduce various vas-based 
methods and the benefits they can offer over systemic approaches. 
2.3.2.1 Injected plugs 
Injected plugs were developed as an attempt to find a potential alternative for vasectomy. The 
plugs are injected in liquid form, into the vas deferens and harden over time to form a plug to 
block the flow of sperm. Two types of plugs have been developed: medical grade 
polyurethane (MPU)
77
 and medical grade silicone rubber (MSR).
78
 Sponsored research has 
been ongoing since the 1980s but unfortunately results varied and it was estimated that the 
device takes 18 to 24 months to work effectively. In addition, the total vas occlusion 
approach will most likely result in the development of antisperm antibodies, which will lead 
to irreversibility, even after plug removal. Furthermore, the plug may lead to rupture of the 
vas.
79
 Due to the lack of promising results, the studies have since been abandoned. 
2.2.4.1 Intra Vas Device (IVD) 
The intra vas device (IVD) is similar in function to a vasectomy, except it leaves the vas 
deferens intact. The device is comprised of a tiny set of implants that blocks the flow of 
sperm.
80
 The device offers several advantages over injected plugs. Among them the most 
substantial advantage is the size of the preformed plug in relation to the size of the vas 
deferens could be controlled. This will relieve stress and avoid the possible rupture of the vas. 
In addition, the anchoring mechanism can prevent the migration of the plug along the length 
of the vas. Currently, two types of IVD are employed in clinical trials. The first is soft 
silicone plugs made by the Shepard Medical Company in the United States. The other 
consists of a urethane tube lined with a small nylon sieve developed by the Foshan Medical 
Company in China. The development of both these devices was inspired by the previous 
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The United States design is sized to the width of the recipient's vas deferens and inserted with 
a patented insertion tool. Two plugs are inserted in the same vas deferens tube, with a small 
space in between, to ensure effectiveness. Movement of the plugs is prevented by the 
insertion of small sutures, anchoring them to the wall. 
The Chinese IVD (Figure 2.4) is a urethane tube closed at one end, lined with medical grade 
nylon mesh, and operates as a filter to capture and trap sperm. One tube is inserted in each 
vas deferens tube. A small hole at the closed end allows the flow of fluid, however sperm 
gets trapped. The design aims to prevent the build-up of pressure on the epididymis, as in the 
case of a vasectomy. Insertion of this device can be performed using a non-surgical procedure 
in less than 20 minutes. A small opening is made in the wall of the vas to allow insertion of 
the IVD. The IVD is anchored in place by a tiny suture outside the vas to keep it from 
dislodging. An additional form of contraception is required for 3 months after IVD insertion, 





Figure 2.4 Schematic diagram of the Chinese IVD. 1, substantial head; 2, shell; 3, nylon thread (medical 




Removal of the IVD is accomplished by a small incision over the plugs to obtain access. 
Reversal, however, will be faster and more cost effective in the case of an IVD compared to 
vasovasostomy. A study of IVD reversal in primates delivered encouraging results, however 
reversal has not been tested in humans.
81
 
A comparative study was performed on the Chinese IVD to the no-scalpel vasectomy 
(NSV).
82
 Results indicated less side effects of the IVD group than the NSV group with a 50% 
reduction in tenderness and pain. No issues of spontaneous reversal of the IVD group 
compared to a few in the NSV group. 
Stellenbosch University  https://scholar.sun.ac.za
Chapter 2: Historical Background 
 
18 
2.2.5 Present Vas-based approaches 
2.2.5.1 Reversible inhibition for sperm under guidance (RISUG) 
Guha et al. introduced reversible inhibition of sperm under guidance (RISUG) in 1979, where 
a solution of poly(styrene-co-maleic anhydride) (SMA) in dimethyl sulfoxide (DMSO) 
solvent is injected into the vas deferens to inhibit the flow of sperm.
83,84
 The method has been 
under research ever since and aims to partake as a promising alternative to a vasectomy, even 
though the mode of action of the polymeric gel is not fully understood.
85
 Guha and co-
workers hypothesised that the mode of action might be due to a pH lowering effect caused by 
hydrolysis of the polymer in the presence of water in spermatic fluid.
86
 An additional 
hypothesis given by Guha is that upon conversion to the hydride, the formed positive charges 
attract negative charged sperm, causing a charge imbalance, killing the sperm.  
This non-surgical procedure is achieved by the injection into the vas deferens through the 
intact scrotal wall, resulting in minimal recovery time of the patient. Within a few minutes of 
injection, the polymeric gel anchors itself to the folds of the inner wall of the vas deferens. 
During the process, the polymer doesn't degrade, as in the case of most contraceptive devices, 
which makes it suitable for long-term use. The advantages of RISUG over vasectomy are the 
absence of the formation of antibodies and granulomas. RISUG still allows fluids to pass 
through, reducing the incidence of back-pressure that causes antibody formation. In addition, 
the process of injection doesn’t result in sperm leakage into surrounding tissue, the main 
reason for granuloma formation. Side effects in humans given RISUG included only minor 
pain and swelling in the testes immediately after treatment, which dissipated with a couple 
weeks. Granulomas, autoimmune responses, and prostate issues were not observed. 
Reversibility is achieved by flushing out the polymer through the injection of a sodium 
bicarbonate (NaHCO3) or DMSO solution into the vas deferens via the scrotal wall.
87,88,89
 
Clinical tests were performed in 1979 on male rats, followed by Phase 2 of the clinical trial in 
1997 with injection of the polymer into healthy adult male monkeys to establish the degree of 
fertility control over a period of one year.
90
 No pregnancies occurred for the duration of the 
study. Short term studies on reversal in male rats, by flushing out the polymer with DMSO 
solution, resulted in 100 % fertility 90 days after reversal.
91
 Long-term effects of RISUG and 
its reversal by DMSO and NaHCO3 have not been thoroughly investigated. Phase 3 clinical 
trials are currently ongoing in India to gain more insight into long-term effects of this method 
on humans. Furthermore, clinical trials of RISUG are underway in the United States under 
the trade name Vasalgel. 
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2.3 Acceptability of current researched methods 
Additional male contraceptive options are required to control population growth and prevent 
unwanted pregnancy. Existing male methods of contraception are effective but have 
limitations. Emerging research is opening doors for novel methods regarding male 
contraception, providing better alternatives other than the existing methods in the near 
future.
92
 However, acceptance of the majority of these methods has been proven challenging 
due to the side effects or reversal issues. Male hormonal methods as male contraception are 
effective, reversible, and seem safe. However, for reasons not entirely understood, not all 
men respond to treatment. This effectively means that men should be screened first in order 
to determine if they would be eligible for this method. In addition, hormonal methods offer 
health risks such as loss of androgenicity, affecting the libido and characteristics of the sex 
organs, resulting in negative psychotropic effects such as irritability, anxiety and 
depression.
93
 Common side effects such as acne and suppression of HDL cholesterol were 
experienced in clinical trials. Overall, however, the high efficacy of hormonal contraceptives 
might outweigh the concerns of side effects, which can be suppressed with improved 
optimised regimens in the near future. Hormonal and non-hormonal systemic methods with 
the requirement of weekly or monthly injections are the biggest disadvantage to these 
options, since the mode of delivery is a very important aspect in the acceptability of a 
contraceptive method.  
From the overview of methods in development presented, the most promising new approach 
appears to be RISUG and Vasalgel, a vasectomy alternative, with the injection of a polymeric 
gel into the vas deferens. The current results have shown this method to be minimally 
invasive and with marginal side effects. It satisfies the greater amount of needs required by 
an ideal contraceptive and has shown superior results in clinical trials. Despite the fact that 
these gels are still in research stages, they have proven to have a great deal of potential for the 
near future on contraception in males. 
The current global unsatisfied need for more affordable and effective contraceptives indicates 
the requirement of further technological advancement or innovations to products. Further 
research in the improvement of potential methods, such as contraceptive hydrogels will be 
extremely useful due to increased demand that there is yet a male contraceptive to be 
developed to satisfy all the desired criteria. Further research in this aspect would be 
extremely valuable to the many couples who do not wish to have children, but do not want to 
give up their health and future fertility.  
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2.4 Our Approach 
The current chapter is mainly focussed on existing male contraception methods, with the 
addition of new approaches that have the potential to provide alternative forms of male 
contraception in the near future.  A promising polymeric gel has shown good results in 
clinical trials, however further improvements of these gels are required due to current 
inadequacies. Shortcomings of the current gel systems include the undesired use of DMSO 
solvent during administration and insufficient reversibility. Investigation into alternative gels 
with improved biocompatible and reversal properties remains elusive and further research is 
required.  
In subsequent chapters, the synthesis of strong, elastic, biocompatible gels with the ability to 
gel in situ at physiologically relevant conditions will be demonstrated. SMA copolymers 
contain the desired biological properties and chemical modification ability to alter the 
mechanical properties of the gels in order to obtain a strong, yet elastic gel for the desired 
application. The crosslinking densities can be controlled by variation of the polymer 
composition and degree of functionalization of the SMA polymer. It will be shown that 
reversibility of these gels is easily achieved by the addition of non-harmful additives to 
readily dissociate the gels.    
Ultimately, the synthesis of a suitable polymeric gel with appropriate swelling and 
viscoelastic properties to satisfy the requirements of an ideal contraceptive would provide an 
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The discovery of reversible-deactivation radical polymerisation (RDRP) has induced 
extensive research efforts over the past few decades.
1
 RDRP offers control over structural 
parameters by achieving simultaneous growth of all chains through reduction of irreversible 
termination reactions. This living behaviour is accomplished by the facile equilibrium of 
dormant and active propagating radicals and ultimately termination is minimised.
2
 As a 
result, well defined polymers with controlled molecular weight, narrow molecular weight 
distribution and complex architectures can be synthesised. The most prominent of RDRP 
techniques used in contemporary polymerisation are reversible addition fragmentation chain-
transfer polymerisation (RAFT)
3,4





. RAFT polymerisation is considered the most 
robust and versatile method of all RDRP techniques. It is compatible with a wide range of 
monomers, solvents, initiators and has the ability to synthesise well defined complex 
architectures with high purity.
9




The RAFT technique was first reported in 1998 by the Australian group at CSIRO.
3
 The 
technique requires the presence of an organic addition fragmentation chain transfer agent 
(CTA), also known as a RAFT agent, that contains an active thiocarbonyl thio group.
11,12
 The 
fundamental steps of the mechanism using the RAFT polymerisation method are extensively 
reported in literature.
13
 The success of the RAFT process in terms of controlled molecular 
weight and dispersity is dependent on the effectiveness of the CTA governed by the nature of 
the R and Z substituent on the RAFT agent.
14,15
 The R substituent must be a good leaving 
group stabilising the radical in the pre-equilibrium stage, but also efficiently reinitiate the 
growth of a new chain.
16
 An effective Z group stabilises the intermediate radicals to result in 
reversible fragmentation and activates the C=S bond towards radical addition.
17
 Keddie et al., 
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A key feature of the RAFT process is the ability to retain the thiocarbonyl thio groups, 
present in the initial RAFT agent, in the polymer products.
19
 The presence of these groups 
results in coloured, odorous products which are disadvantageous to certain applications.
20
 A 
variety of effective methods were developed for the post-treatment of RAFT-made polymers 
in order to remove or transform the thiocarbonyl thio groups.
21
 Removal of RAFT end-
groups can be achieved by introduction of various compounds such as a) nucleophiles (e.g. 
primary amines) and reducing agents (e.g. sodium borohydride) to yield thiols
22
 b) 
thermolysis by exposure to heat to leave an unsaturated chain end
21
 c) radical induced 





yield a saturated chain end. For further details on various chain end modification methods, 
the reader is referred to a paper by Moad et al.
25
 
Poly(styrene-co-maleic anhydride) (SMA) copolymers are highly interesting functional 
polymers with eminent chemical and biological features. Chemical modification of the 
polymer can easily be accomplished due to the accessible and reactive maleic anhydride 
residues. Maleic anhydride residues can readily undergo reactions with various compounds 
such as water, alcohols and (primary or secondary) amines. A variety of biological 
applications reported for this synthetic biocompatible polymer include a polymer–protein 
conjugate of SMA with a potent antitumor polypeptide neocarzinostatin (NCS) as drug 
carrier for targeted treatment of lung and liver cancer.
26,27,28
 Also, SMA and its derivatives 
have been reported in the effective inhibition of HIV-1 infections and as a micellar carrier for 
ovarian cancer drugs.
29,30,31
As such, it is considered an attractive polymer choice in the 
design of a polymeric gel to be injected into the vas deferens as male contraceptive.  
RAFT polymerisation is one of the few RDRP techniques able to successfully control the 
polymerisation of SMA. In addition, it offers the option of further modification of the maleic 
anhydride or chain end functional groups to obtain the desired functionality for hydrogel 
formation. Numerous successful attempts to synthesise well defined SMA polymers via 
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3.2 Results and discussion 
In this chapter, a synthetic route towards the controlled polymerisation of SMA is described. 
In addition, two approaches involving post-polymerisation modification reactions of the 
SMA were investigated, in an attempt to form two different polymeric gels. The rationale 
behind demonstrating these two different approaches is to show that SMA can be chemically 
modified at different sites to introduce new functional groups to the polymer that can lead to 
hydrogel formation as will be discussed in Chapter 5. For the SMA polymer, this can be 
accomplished either through modification of the anhydride residues in the SMA backbone or 
through the chain end modification of the available thiocarbonyl thio groups of the RAFT-
made SMA. The former crosslinks by the addition of a multifunctional polymer while the 
latter will result in chain coupling to form high molar mass chains composed of low molar 
mass SMA segments, ultimately leading to physical hydrogel formation. 
3.2.1 Synthesis and Characterisation of RAFT system 
Ethyl 2-(((butylthio)carbonothioyl)thio)-2-methylpropanoate (1) was selected as the CTA of 
choice for synthesis of SMA since the R and Z groups are suitable for effectively controlling 
styrene and maleic anhydride monomer species.
18
 
Synthesis of RAFT agent 1 is shown in Scheme 3.1. Ethyl-2-bromo-2-methylpropionate was 
reacted with potassium butyl trithiocarbonate, through nucleophilic substitution, to attain the 
desired RAFT agent 1. The product was purified by column chromatography and 
1
H NMR 
spectroscopy confirmed the successful synthesis of RAFT agent 1. 
 
Scheme 3.1 Synthesis of RAFT agent via nucleophilic substitution reaction: a) acetone, r.t. 
3.2.2 Polymerisation of SMA 
RAFT agent 1 was employed to control the polymerisation of SMA (Scheme 3.2) at 70 C, 
using AIBN as thermal initiator. The RAFT agent/initiator (AIBN) ratio was kept constant at 
5:1 to ensure only a negligible amount of chains is initiator-based. Results of various targeted 
degrees of polymerisation (DP) are summarised in Table 3.1. 
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Scheme 3.2 RAFT polymerisation of SMA 
 
Table 3.1 Polymerisation conditions and results for SMA synthesised with RAFT agent 1 
a Conversion.  
b Theoretical molar mass was calculated as follows : 𝑀𝑛,   𝑡ℎ𝑒𝑜 =
𝑀𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑚𝑜𝑛𝑜𝑚𝑒𝑟𝑠
𝑀𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑅𝐴𝐹𝑇
× 𝛼 × 𝑀𝑟(𝑆𝑀𝐴) + 𝑀𝑟(𝑅𝐴𝐹𝑇) …. Equation 1 
c Mn,, SEC in DMAc based on PMMA standards 
d Mn, NMR determined as follows : 𝑀𝑛,   𝑁𝑀𝑅 =  
∫ 𝑃𝑜𝑙𝑦𝑚𝑒𝑟𝑖𝑐 𝑝𝑟𝑜𝑡𝑜𝑛𝑠 𝑜𝑓 𝑠𝑡𝑦𝑟𝑒𝑛𝑒/5
∫ 𝑐ℎ𝑎𝑖𝑛 𝑒𝑛𝑑 𝑝𝑟𝑜𝑡𝑜𝑛𝑠/2
× 𝑀𝑟𝑆𝑀𝐴 + 𝑀𝑟(𝑅𝐴𝐹𝑇)  …… Equation 2 
e Đ is the molar mass dispersity. 
 
Molar mass (Mn) and dispersity (Đ) of the synthesised polymers were determined by size 
exclusion chromatography (SEC) in N,N-dimethylacetamide (DMAc), calibrated with 
PMMA standards. For an RDRP, Đ values below 1.2 from SEC are indicative of good 
control. Narrow molecular weight distributions and Đ values for all polymerisations indicate 
that all reactions were effectively controlled. 
1
H NMR spectroscopy showed that the majority 
of RAFT end-groups were retained. The minor discrepancy between Mn,theo and Mn,NMR is due 
to the latter being based on the assumption that each chain is end-capped with a thiocarbonyl 
thio moiety. Nonetheless, all Mn data sets were in excellent agreement with each other. 
Polymer sample 1a was chosen as model system for all modification reactions in Approach 1 

















































































1a 50 80 Dioxane 4 70 4324 4614 4447 1.18 
1b 100 75 Dioxane 4 70 7863 9141 7987 1.11 
1c 200 68 Dioxane 6 70 14030 15767 14443 1.15 
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3.2.3 Post-polymerisation modification of SMA 
3.2.3.1 Approach 1: Modification with 3-aminophenyl boronic acid 
This first approach involved the a) radical induced removal of the thiocarbonyl thio end-
group on SMA 1a, followed by b) chemical modification of the anhydride units with 3-
aminophenyl boronic acid (BA) (Scheme 3.3). The reaction between the anhydride units and 
a primary amine is known to be very rapid and straight forward.
35
 Hydrogel formation, c) will 
be studied in Chapter 5 where gelation is achieved by mixing aqueous solutions of the 
boronic acid modified SMA (SMI-BA) with poly(vinyl alcohol) (PVA). The crosslinking 
reaction, resulting in gel formation, is based on reversible ester formation between the 
boronic acid groups, in SMI-BA, and the 1,3 diols in PVA.
36
 The formation, swelling 





Scheme 3.3 Approach 1 - Modification of SMA: (a) EPHP, 110 C ; (b) 3-aminophenyl boronic acid, DMF, 
170 C; (c) PVA, H2O, r.t. 
SMA 1a was treated with N-ethylpiperidine hypophosphite (EPHP) to yield odourless, 
colourless SMA 2a saturated chain ends. The exceptional feature about hypophosphite salts 
is that it, and all by-products formed in the reaction, are water soluble.
37
 This allows for easy 
removal and purification of the polymer by a simple water wash.  
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Purified SMA 2a was modified with BA, to various degrees, via imidisation of the anhydride 
groups to yield three different functionalised SMI-BA polymers. Alteration of the percentage 
of functionalization will allow the synthesis of gels with various cross-linking densities by 
introducing a controlled amount of functional groups available to crosslink. Change in 
crosslink density of the gel, upon mixture with PVA, results in gels with various viscoelastic 
properties and gelation times. This allows us to ultimately narrow down a suitable gel 
composition with the optimum physical and mechanical properties for contraceptive 
application.  Attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopy 
was used as a technique to characterise and monitor the extent of imidisation of the anhydride 
peaks of three modified SMI-BA (25%, 50% and 100%) polymers (Figure 3.1). 
 
Figure 3.1 Extent of imidisation monitored via ATR-FTIR: (a) SMA (b) SMI-25BA (c) SMI-50BA (d) 
SMI-100BA 
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due to symmetrical and asymmetrical stretching of the anhydride moiety. The small peak at 
3044 cm
-1 
is due to the sp
2
 aromatic C-H bend vibrations of the styrene unit and the bands at 
2900 cm
-1 
is due to the sp
3
 aliphatic C-H bending vibrations of the polymer chain.
38,39
 
After imidisation of SMA 2a with BA, followed by heat-induced ring closure, a new strong 
band at 1690 cm
-1 
is observed due to successful formation of the imide groups in all three 
SMA-BA polymers (b-d).
40
 Conformation of ring closure is established by the absence of 




indicative of N-H bending.
41
 The gradual decrease of the 




) followed by the gradual increase of the 
absorption band of the imide at 1690 cm
-1
, after modification with increased amounts of BA 
(a to d) represent the increased incorporation of BA in the SMA 2a polymers. Complete 
imidisation of SMI-100BA (d) is attributed by the absence of anhydride peaks. The broad 
band at 3400 cm
-1 
is assigned to the stretching of the hydroxyl groups, present after 
incorporation of BA, due to diol functionality of BA. The intensities of peaks in ATR-FTIR 
can be used as a technique to give a qualitative measurement and an estimated quantitative 
value of modification. Since peak overlapping was evident in the spectra, an alternative 
method for quantitative chemical analysis can be achieved through analysis of absorbance 
with UV-vis spectroscopy with the employment of a dye reacting with the functional diol 
groups on BA. 
Boronic acids are well known to form crosslinks with compounds containing diols through 
reversible ester formation.
42
 Alizarin Red S (ARS) is an anthraquinone dye that contains 1,2-
cis diols that have the potential to interact covalently with the BA diols.
43
 The concentration 
of BA present in the modified SMI-BA polymers was determined using ARS, by a change in 
absorbance as a response to the quantity of boronic acid-diol crosslink formation, via UV-vis 
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The extent of high-affinity complex formation between the diol functionality present in the 
dye and boronic acid is visually observed by a colour change from deep red to yellow with 
increase in boronic acid-diol complex formation.
44
 As a result, the UV-Vis absorbance 
spectrum undergoes a hypsochromic shift from max = 515 nm to max = 468 nm. A solution of 
ARS was prepared in phosphate buffered saline (PBS) of pH 7.4 and treated with various 
dilutions of BA (0 M – 250 M). The mixtures were equilibrated for 30 minutes before the 











Figure 3.3 (A) UV-Vis absorption spectra changes of ARS (250 M) with increased concentration of BA 
(0 M – 250 M) in phosphate buffered saline (0.008 M) (B) Calibration curve of the peak area ratio 
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It is seen from the above spectra that the increased concentration BA up to 31 M resulted in 
a decrease in peak intensity followed by a slight shift to shorter wavelength. Further increase 
in the BA concentration from 31 M resulted in increased absorbance with a larger shift to 
lower wavelength. This typical behaviour observed in the UV absorbance has extensively 
been reported in literature.
45,46
 Moreover, the deconvoluted peak area ratio of 468 nm and 
515 nm with various BA concentrations is useful for determining the unknown concentration 
of BA in a sample. Figure 3.3B shows a linear relation of the deconvoluted peak area ratio as 
a function of BA concentration.  
Subsequently, the UV-vis absorption spectra were recorded for SMI-25BA, SMI-50BA and 
SMI-100BA in Figure 3.4. All SMI-BA solutions in PBS were prepared 24 hours before 
measurements to obtain clear solutions, due to the requirement of prolonged stirring, 
solubility dependant on partial hydrolysis of the anhydride groups. The mixtures were 
equilibrated for 30 minutes before the measurement of every spectrum. 
 
Figure 3.4 Absorption spectra of ARS (250 M) with SMI-25BA, SMI-50BA and SMI-100BA in PBS to 
determine the mole fraction of BA in the functionalised polymers  
The hypsochromic shift for the modified polymers from max = 490 nm to max = 475 is 
typical of increased number of boronic acid-diol crosslink formation with increased BA 
groups available on the modified polymers. The deconvoluted peak area ratio for the three 
samples were determined and plotted on the calibration curve to determine a quantitative 
concentration of BA present in the SMI-BA polymers synthesised. The data obtained from 
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Table 3.2 UV-vis data obtained from the SMI-BA polymers 
a mole fraction of maleic anhydride (MA) residues in 1 mg SMA polymer before modification  
b mole fraction of maleimide (MI) residues in SMI-BA polymers at 100% conversion  
c mole fraction of BA in SMI-BA polymers determined from the calibration curve 
 
UV-vis confirmed that SMI-25BA portray the lowest BA concentration, followed by SMI-
50BA and ultimately SMI-100BA. The mole fraction of BA in the polymer samples was 
determined from the calibration plot and compared to the mole fraction of modified maleic 
anhydride residues in the polymers after modification. The results are in excellent agreement 
with what would be expected for the modified polymers. From the data it is clear that SMI-
100BA is in very close proximity to the expected value for 100% conversion. This is due to 
the addition of BA in excess to ensure all BA reacted with the available reactive maleic 
anhydride residues.  
These results confirmed the successful incorporation of BA functional groups via the maleic 
anhydride groups as an effective method for preparation of functionalised SMA polymers 
with good conversions. UV-vis spectroscopy can effectively be used as a tool for 
the quantitative determination of BA functional groups along low molar mass polymers. 
3.2.3.2 Approach 2: Modification of RAFT end-groups to form thiols 
The second approach involves the a) reduction of RAFT-made SMA with sodium 
borohydride (NaBH4), to yield thiol end-groups. The resulting polymer was b) exposed to air 
in an attempt to link the thiols into disulphides under oxidising conditions (Scheme 3.4)  
Scheme 3.4 Reduction of RAFT-made SMA to yield thiol end-groups in an attempt to form disulphides 


















SMI-25BA 1 4.94 x 10
-6  1.23  x 10-6 490 44.29 1.10 x 10-6 
SMI-50BA 1 4.94 x 10
-6 2.47 x 10-6 485 89.49 2.21 x 10-6 
SMI-100BA 1 4.94 x 10
-6 4.94 x 10-6 475 195.94 4.86 x 10-6 
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It is readily known in literature that under oxidising conditions the thiol end group termini of 
most polymers readily oxidise to form dimers containing disulphide bridge-linkages between 
two polymer segments.
47
 The reduction of thiocarbonyl thio end-groups of SMA 1a in the 
presence of NaBH4 was performed in water to yield SMA 3a. Successful cleavage of the 
thiocarbonyl thio groups is visually noted by a solution colour change, from yellow to white. 
It was hypothesised that the SMA 3a polymer with thiol functionality will dimerise into 
disulphide bridge-linkages, coupling two SMA chains with same approximate molar mass. 
This will result in polymer SMA 4a, double the molar mass of SMA 3a. 
The use of difunctional RAFT agent such as 1,4-bis(2-(thiobenzoylthio)prop-2-yl) can be 
employed to prepare α,ω-bis-(dithioester)-functionalised polystyrene, which can be further 
converted into terminal thiol groups to couple and form linear polymers when subjected to 
oxygen.
48
 This concept can be applied to our polymer system to introduce thiols on both sides 
of the polymeric chain to form consecutive disulphide bridges, resulting in high molar mass 
chains, made up of small SMA segments. This will result in a linear increase in molar mass 
of SMA chains necessary for hydrogel formation. The formation of disulphide linkages can 
be observed form SEC, by a doubling in the molar mass distribution (MMD) due to a 
disulfide bridge linking two chains together.
49
 The SEC chromatograms obtained for SMA 







Figure 3.5 SEC chromatogram of SMA 1b Left: a) initial and b) after reduction showing absence of 
disulphide formation. Right: UV320 indicating successful cleavage of the chromophore 
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The molar mass of the polymer after reduction with NaBH4 and exposure to air have 
approximately the same molar mass as the polymer prior to reduction. The lack of doubling 
in molar mass suggests that no disulphide formation took place between polymer chains. This 
can either be due to unsuccessful reduction of the polymer SMA 1a to convert to thiol-
terminal SMA 3a polymer or a side reaction is hampering the disulphide coupling form SMA 
3a to SMA 4a. The UV signal at 320 nm, attributed to the presence of the thiocarbonyl thio 
moiety in SMA 1a show intense absorbance after the polymerisation, an indication that the 
polymer chains do contain the RAFT-moiety as an end group.
50
 After treatment with NaBH4, 
the UV signal at 320 nm disappeared, indicative of successful cleavage of the thiocarbonyl 
thio moiety and the formation of SMA 3a polymer. After exposure to air for 24 hours, to the 
oxidation of the thiol-terminal SMA 3a attempt the formation of polymer SMA 4a by, a lack 
in the doubling of the molar mass was observed. The result indicates that the thiocarbonyl 
thio moiety in SMA 1a was successfully cleaved to yield the thiol-terminal SMA 3a 
polymer, however after exposure to air for 24 hours to dimerise the polymer, SMA 4a was 
never obtained.  
Xu et al. reported aminolysis of poly(methyl methacrylate) (PMMA) resulting in formation 
of a thiolactone terminus, hindering disulphide formation.
49
 The thiol end-group generated 
during aminolysis with hexylamine cyclizes through a backbiting reaction, resulting in the 
thiolactone structure. The same reaction was observed in poly(N,N-dimethylaminoethyl 
methacrylate) and poly(lauryl methacrylate). All of the above polymers have similar structure 
as ring opened SMA, as such it was speculated that this side reaction might possibly happen 
during reduction of the SMA polymer. A model study was subsequently carried to test this 
hypothesis. The model study will be described in Chapter 4.  
3.3 Conclusion 
It was demonstrated that RAFT agent 1 is sufficient to stabilize the controlled radical 
polymerisation of SMA. Two synthetic approaches, with very different chemistry routes, 
were carried out in an attempt to form two different modified SMA samples suitable for 
hydrogel formation.  
In approach one, the successful synthesis of SMI-BA polymers, by introduction of 3-amino 
phenyl boronic acid (BA), functional polymers were synthesised via the reactive maleic 
anhydride residues. The polymers were successfully characterised via ATR-FTIR 
spectroscopy and the degree of modification was quantified using UV-vis spectroscopy.  
Stellenbosch University  https://scholar.sun.ac.za
Chapter 3: Synthesis, Modification and Characterisation of SMA 
 
38 
It was found that the reduction of SMA in the second approach resulted in the successful 
cleavage of the thiocarbonyl thio groups, however disulphide formation was never observed. 
It was speculated that this was a result of thiolactone ring formation via the backbiting of the 
thiol group toward the penultimate unit, eliminating the possibility of disulphide formation. 
However this requires further investigation. 
3.4 Experimental 
3.4.1 General experimental details 
All chemicals and solvents were purchased from commercial sources and used without 
further purification, unless stated otherwise. Styrene (Plascon Research Centre, University of 
Stellenbosch, estimated purity ~99% by 
1
H-NMR) was washed three times with an aqueous 
0.3 M KOH solution to remove the inhibitor and subsequently distilled under reduced 
pressure. 2,2’-Azobis(isobutyronitrile) (AIBN) (Riedel de Haën) was recrystallized from 
methanol and dried under vacuum at ambient temperature. Distilled deionised water was 
obtained from a Millipore Milli-Q purification system and used in all experiments. Reactions 
were monitored using thin layer chromatography (TLC), utilising Machery-Nagel Silica gel 
60 plates (particle size 0.063-0.2mm/ 70-230 mesh) with a UV 254 fluorescent indicator. 




C-NMR spectra were recorded on a Varian VXR-Unity (300 MHz or 400 
MHz) spectrometer at room temperature. Samples were prepared in deuterated solvents 
obtained from Cambridge Isotope Labs. Integration of spectra was carried out using 
Mestranova 9.0. Chemical shifts were reported in parts-per-million (ppm), referenced to the 
residual solvent protons. Abbreviations for NMR splitting patterns are designated as s 
(singlet), d (doublet), t (triplet), q (quartet) and m (multiplet), whereas coupling constants (J) 
are reported in hertz (Hz). 
Size exclusion chromatography (SEC) was performed on a system consisting of a Shimadzu 
LC-10AT isocratic pump, a Waters 717+ autosampler, a column system fitted with a PSS 
guard column (50×8 mm) in series with three PSS GRAM columns (300 × 8 mm, 10 μm, 2 × 
3000 Å and 1 × 100 Å) kept at 40 C, a Waters 2487 dual wavelength UV detector and a 
Waters 2414 differential refractive index (DRI) detector. N,N-Dimethylacetamide (DMAc) 
was used as the eluent, stabilized with 0.05 % 2,6-di-tert-butyl-4-methylphenol (BHT) (w/v) 
and 0.03 % LiCl (w/v), at a flow rate of 1.0 mL.min
-1
. All polymer samples were filtered 
through 0.45 μm GHP filters, to remove impurities, preceding analysis. Molar mass of 
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polymers were determined by calibration using poly(methyl methacrylate) (PMMA) standard 




. Data acquisition was 
performed using Millennium software, version 4. 
Attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopy was 
performed on a Nexus infrared spectrometer equipped with a Smart Golden Gate attenuated 
total reflectance diamond from Thermo Nicolet with ZnSe lenses. Each spectrum was 
scanned 32 times with 4.0 cm
-1
 resolution. The data analysis was performed with Omnic 
Software version 7.2. 
UV-Vis spectra were measured using a Perkin Elmer photodiode array spectrophotometer. 
The model of the spectrophotometer was a Lambda 20 which comprised a holographic 
monochromator, pre-aligned deuterium and halogen lamps and a photodiode array detector. 
Samples were measured in a 2 mm  2 mm cuvette at 25 C. UV Winlab (version 2.0) 
software was used for data acquisition and processing. 
3.4.2 Synthetic procedures 
Synthesis of ethyl 2-(((butylthio)carbonothioyl)thio)-2-methylpropanoate (1):  
Potassium phosphate tribasic (16.6 g, 78.2 mmol) was dissolved in acetone in a 500 mL 
round bottom flask and stirred for 5 hours to form a yellow suspension. 1-butanethiol (8.0 
mL, 74.2 mmol) was added and the mixture was stirred for an additional 1 hour. Carbon 
disulphide (9.1 mL, 15.1 mmol) was slowly added drop-wise and the solution was allowed to 
stir for 2 hours at 0 C. ethyl 2 bromo-2-methylpropionate (13.7 g, 70.0 mmol) was added 
and the solution was allowed to stir for 24 hours at room temperature. The reaction mixture 
was filtered and concentrated. The residue was diluted with 10% HCl solution and stirred 
overnight at room temperature. The organic layer was extracted with hexane and dried over 
anhydrous MgSO4. The solvent was removed under vacuum and the residual crude product 
was purified by column chromatography, with petroleum ether/ethyl acetate (9/1) as eluent, 
to yield a yellow solid (12.78 g, 65% yield). 
1
H NMR (400 MHz, CDCl3) δ (ppm) = 4.15 (t, 
J=7.1 Hz, 2H), 3.27 (t, J=7.4 Hz, 2H), 1.68 (s, 6H), 1.66-1.60 (m, 2H), 1.45-1.34 (m, 2H) 
1.23 (t, J=7.1 Hz, 3H), 0.91 (t, J=7.4 Hz, 3H) 
13
C NMR (151 MHz,CDCl3) δ (ppm)  221.44, 
172.98, 62.04, 56.04, 36.67, 30.05, 25.47, 22.17, 14.12, 13.70. MS (ESI): m/z = 281.07 m/z 
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Polymerisation of Styrene-co-maleic anhydride (SMA): 
Styrene (843 mg, 8.1 mmol), maleic anhydride (834 mg, 8.5 mmol), AIBN (40.53 mg, 0.247 
mmol), RAFT agent 1 (346.18 mg, 1.23 mmol) and dioxane (2.5 mL) were added to a 20 mL 
pear shape flask. The reaction mixture was degassed with argon for 45 minutes and placed in 
an oil bath at 70 C for 4 hours. The solution was precipitated from isopropanol twice and the 
polymer was dried under reduced pressure overnight at room temperature to yield a the 
polymer product (1025 mg, 61% yield, Mn = 3717 g/mol, Đ = 1.23) 
Synthesis of Styrene-aminophenylbronic acid maleimide copolymer (SMI-100BA): 
SMA (0.200 g, 1.00 mmol MA residues) was dissolved in 3 mL DMF in a 50 mL round 
bottom flask. 3-aminophenylboronic acid (BA) (0.140 g, 1.05 mmol) was placed in a 
dropping funnel with 5 mL DMF and added drop-wise to the SMA solution, at room 
temperature, over a period of 30 minutes. The solution was placed in a 155 C oil bath for 7 
hours for complete imidisation of maleic anhydride groups. The solution was cooled and 
precipitated in isopropanol, re-dissolved in dioxane and precipitated again in isopropanol. 
The light brown polymer was dried in vacuum at 40 C for 24 hours to yield SMA-100BA 
(0.302 g, 95% yield).  
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4 Chapter 4: Dimerisation Model Study of SMA 
 
4.1 Introduction 
The reaction of thiocarbonyl thio groups with excess amine (aminolysis) is one of the most 
versatile and widely used methods of RAFT end group conversion, resulting in the formation 
of thiol-terminal chain end polymers, capable of undergoing multiple reactions with various 
functional groups.
1,2
 It is well known that thiol moieties readily form disulphides through 
mild oxidation, followed by easy reversal by the addition of a reducing agent. Whittaker et al. 
reported the ease of disulphide formation of thiol-terminal polystyrene synthesised with a 
difunctional RAFT agent, followed by aminolysis and oxidation to result in linear, high 
molecular weight multiblock polymers.
3
 This attractive chain end manipulation strategy 
allows for a variety of polymers to be reversibly crosslinked under mild conditions, with 
disulphide bridge formation by exposure to air, easily cleaved again under reducing 
conditions.  
It has been shown that the thiols formed during the aminolysis of various methacrylates 
undergo a side reaction to hinder any possibility of disulphide formation. Thiol-terminal 
poly(methyl methacrylate) (PMMA) (Scheme 4.1) is found to attach to the penultimate unit 
in the chain by backbiting, resulting in the formation of a thiolactone ring.
4
 In addition, the 
side reaction is promoted by the stability of the five-membered ring.
5
 Furthermore, 
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While such cyclisation reactions are undesirable if the aim is to obtain free polymeric thiols, 
inhibition of thiolactone ring formation in PMMA can be accomplished by the introduction of 




The present chapter investigates the possibility of thiolactone ring formation of thiol-terminal 
SMA described in Chapter 3. In this model study, the controlled synthesis of RAFT-made 
polymers, structurally similar to SMA, is described. The polymers chosen for this study 
represent both possibilities of either a maleic anhydride or styrene monomer next to the 
thiocarbonyl thio RAFT end group. In addition, reduction of the polymers was carried out to 
ensure thiol-terminal chain end polymers capable of disulphide formation. The extent of 
disulphide formation in the polymers is studied in order to determine the structural conditions 
that subsequently hinder disulphide formation in SMA. Furthermore, an attempt to introduce 
a short polystyrene block to the SMA macro-RAFT agent to promote disulphide formation is 
discussed.   
4.2 Results and discussion 
4.2.1 Model study 
It is well known that thiol-terminated poly(N-vinylpyrrolidone) (PVP) polymer chains readily 
form disulphides under oxidising conditions.
7
  Xanthate end functional PVP was prepared via 
(S)-(2-cyano-2-propyl)-O-ethyl xanthate-mediated polymerisation.
8
 A common aminolysis 
procedure was applied to the synthesised polymer as shown in Scheme 4.2. 
 
Scheme 4.2 Reaction scheme of intermolecular disulphide starting from functionalised PVP. The applied 
reaction conditions include a) hexylamine, 20 eq., DCM, r.t b) O2, 24 h, r.t. 
Disulphide formation is observed as a doubling of molar mass which can be seen as a shift in 
the molar mass distribution (MMD) (Figure 4.1) In addition, the absence of the UV (280 nm) 
signal attributed to absorbance by the xanthate functionality, is a clear indication of the 
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Figure 4.1 DRI and UV SEC molar mass distribution from PVP 1c to PVP 2c confirming successful 
disulphide formation 
Since the SMA copolymer is considered strictly alternating in structure, the monomer unit 
next to the thiocarbonyl thio group can either be a styrene or a maleic anhydride. As such, the 
polymers chosen to participate in the model study, structurally similar to SMA (Figure 4.2) 
are the following: polystyrene (PS) represents the former case where a styrene group is 
adjacent to the RAFT end group and PMMA and poly(methyl acrylate) (PMA) systems the 
latter of having a maleic anhydride adjacent to the thiol after reduction. The extent of 
disulphide formation was investigated with SEC.  
 
Figure 4.2 Polymers structurally similar to SMA 
 
The above mentioned polymers were successfully synthesised using ethyl 2-
(((butylthio)carbonothioyl)thio)-2-methylpropanoate (RAFT agent 1) synthesised in Chapter 
3. AIBN and 1,1′-azobis(cyanocyclohexane) (ACHN) were used as thermal initiators. All 
polymerisations were carried out under an inert atmosphere. Reductions of the polymers were 
carried out using excess NaBH4 (20 equivalents). Polymerisation conditions and SEC results 
are summarised in Table 4.1. 
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Table 4.1 Synthesis and characterisation of model study polymers 
a Mn,SEC obtained from SEC in DMAc based on PMMA standards before reduction
 b Mn,SEC after reduction 
c UV at 280 nm 
Low dispersities, Đ ≤ 1.26, of synthesised polymers 1a-1g are indicative of good 
polymerisation control. The UV signals (320 nm), attributed to the thiocarbonyl thio moiety 
of the synthesised SMA, PS, PMA, and PMMA polymers show intense absorption.
10
 It is 
therefore concluded that all chains do contain the RAFT-moiety as an end group. Reduction 
of polymers 1a-1g results in the disappearance of UV absorbance at the characteristic 
wavelength, indicative of the successful cleavage of the thiocarbonyl thio moiety. Disulphide 
formation of PVP and PS was confirmed by a doubling in molar mass after exposure to air 
for 24 hours. PMMA, PMA and SMA exhibit a molar mass approximately the same as the 
starting material, which suggests the lack of disulphide formation.  
13
C NMR was used as an additional technique to determine if these low molar mass polymers 
i.e. PMMA, PMA and SMA formed thiolactone ring end species. Thiolactone ring formation 
of PMMA in Figure 4.3 is confirmed by the disappearance of the carbonyl carbon (–C=S)S- 
at 221 ppm and the appearance of a new signal at 210 ppm, assigned to the carbonyl carbon 
of the thiolactone ring. This value of chemical shift is in close proximity to the reported 
values of Engel et al.
11






















1a SMA 4614 1.18 NaBH4 24 Yes 2a 4717 1.23 No 














2c 2219 1.14 No
c 














2e 5518 1.24 No 
2f 5509 1.22 No 
1e PMA 3416 1.16 NaBH4 24 Yes 
2g 3643 1.20 No 
2h 3476 1.23 No 
1f PMMA 3976 1.18 NaBH4 24 Yes 
2i 3890 1.31 No 
2j 3743 1.31 No 
1g PMMA 10939 1.26 NaBH4 24 Yes 2k 12770 1.25 No 
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C NMR spectra confirming thiolactone ring formation after treating PMMA 1f with a 
reducing agent to result in PMMA 2i  
 
Since ring-opened SMA is structurally similar to acrylates, it was hypothesised that the 
polymer might also undergo thiolactone ring formation. It was speculated that this side 
reaction is the main interference in disulphide formation of our polymer after numerous 
attempts resulted in no doubling in molar mass after confirmed disappearance of the 
thiocarbonyl thio group from SEC in Table 4.1. If thiolactone ring formation was indeed the 
cause of this, an expected up field shift of the carbonyl carbon at 222 ppm  in close proximity 
to 210 ppm can be confirmed by 
13





Stellenbosch University  https://scholar.sun.ac.za






C NMR spectra confirming thiolactone ring formation after treating SMA 1a with a reducing 
agent to result in SMA 2a 
13
C NMR spectroscopy confirmed the disappearance of the carbonyl carbon at 222 ppm and 
the appearance of a new signal at 209 ppm, assigned to carbonyl carbon of the proposed 5-
membered thiolactone ring formation in SMA 1a polymer with styrene as the terminal 
monomer and maleic anhydride as the penultimate unit. The same result was however not 
observed in synthesis of SMA with maleic anhydride as terminal unit, even though lack of 
disulphide formation was also observed in this case. 
4.2.2 SMA-b-PS diblock synthesis and characterisation 
Introduction of a small block of styrene monomers after the RAFT polymerisation of SMA 
was carried out in an attempt for the polymer to undergo reduction according to the 
mechanism of polystyrene, to result in disulphide coupling under oxidising conditions. Two 
SMA-b-PS diblock polymers were synthesised by chain extending SMA macro-RAFT agent 
1a with approximately five styrene monomer units. Table 4.2 provides a summary of the SEC 
results of the synthesised block copolymers before and after reduction with NaBH4 and 
exposure to air for 24 hours. 
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Table 4.2 SEC results of synthesised SMA-b-PS block copolymers 
a Mn,SEC obtained from SEC in DMAc based on PMMA standards before reduction
 b Mn,SEC after reduction 
A maximum of four PS units at the end of polymer chain 3a is sufficient to prevent 
cyclisation of the penultimate unit. From the SEC chromatogram in Figure 4.5 the doubling 
of the molar mass confirms disulphide formation of the block copolymer 3a to 4a. This is 
followed by the successful cleavage of the thiocarbonyl thio unit by the disappearance of the 
UV signal at 320 nm after treatment with NaBH4.  
 
Figure 4.5 DRI and UV SEC molar mass distribution from SMA-b-PS 3a to SMA-b-PS 4a confirming 
disulphide formation of the block polymer 
4.3  Conclusion 
It was demonstrated that disulphide formation between two polymeric chains is 
predominantly dependant on the structural format of the penultimate and last monomeric 
units next to thiocarbonyl thio group of RAFT-made polymers. The reduction of PVP, PS, 
PMMA, PMA, and SMA polymers prepared by RAFT polymerisation results in polymers 
with thiol termini confirmed by the disappearance of the UV signal of the specified 
chromophore in SEC measurements.  
It was shown, through SEC analysis, that PVP and PS couple through the formation of 
























3a 5654 5001 1.22 SMA22-b-PS4 22 4a 10374 1.28 
3b 5654 5147 1.20 SMA22-b-PS5 22 4b 10367 1.28 
Stellenbosch University  https://scholar.sun.ac.za
Chapter 4: Dimerisation Model Study of SMA 
 
51 
group formed via the backbiting reaction promoted by the stability of the 5-membered ring. 
The thiolactone ring formation in these polymers was confirmed by 
13
C NMR spectroscopy.   
It was established by SEC analysis that extension of the SMA macro-RAFT agent with four 
styrene units was enough to prevent cyclisation and promote disulphide formation of the 
polymer.  
4.4 Experimental 
4.4.1 General experimental details 
All chemicals and solvents were purchased from commercial sources and used without 
further purification, unless stated otherwise. N-vinylpyrrolidone (Aldrich, 99%) was dried 
over molecular sieves and purified by distillation under reduced pressure. Styrene (Plascon 
Research Centre, University of Stellenbosch, estimated purity ~99 % by 
1
H-NMR), methyl 
methacrylate (Aldrich, 99%), methyl acrylate (Aldrich, 99%) were passed through an Al2O3 
column and subsequently distilled under reduced pressure. (2,2’-Azobis(isobutyronitrile) 
(AIBN) (Riedel de Haën) and 1,1′-azobis(cyanocyclohexane) (ACHN) (Aldrich, 98%) was 
recrystallized from methanol and dried under vacuum at ambient temperature. Moisture and 
oxygen sensitive reactions were carried out in an inert argon atmosphere.  
13
C-NMR spectra were recorded on a Varian VXR-Unity (400 MHz) spectrometer at room 
temperature. Samples were prepared in deuterated solvents obtained from Cambridge Isotope 
Labs. Chemical shifts were reported in parts-per-million (ppm), referenced to the residual 
solvent peaks.  
Size exclusion chromatography (SEC) was performed on a system consisting of a Shimadzu 
LC-10AT isocratic pump, a Waters 717+ autosampler, a column system fitted with a PSS 
guard column (50×8 mm) in series with three PSS GRAM columns (300 × 8 mm, 10 μm, 2 × 
3000 Å and 1 × 100 Å) kept at 40 C, a Waters 2487 dual wavelength UV detector and a 
Waters 2414 differential refractive index (DRI) detector. N,N-Dimethylacetamide (DMAc) 
was used as the eluent, stabilized with 0.05 % 2,6-di-tert-butyl-4-methylphenol (BHT) (w/v) 
and 0.03 % LiCl (w/v), at a flow rate of 1.0 mL.min
-1
. All polymer samples were filtered 
through 0.45 μm GHP filters, to remove impurities, preceding analysis. Molar mass of 
polymers were determined by calibration using poly(methyl methacrylate) (PMMA) standard 




. Data acquisition was 
performed using Millennium software, version 4. 
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4.4.2 Synthetic procedures 
Synthesis of ethyl 2-(((butylthio)carbonothioyl)thio)-2-methylpropanoate (1):  
Potassium phosphate tribasic (16.6 g, 78.2 mmol) was dissolved in acetone in a 500 mL 
round bottom flask and stirred for 5 hours to form a yellow suspension. 1-butanethiol (8.0 
mL, 74.2 mmol) was added and the mixture was stirred for an additional 1 hour. Carbon 
disulphide (9.1 mL, 15.1 mmol) was slowly added drop-wise and the solution was allowed to 
stir for 2 hours at 0 C. ethyl 2 bromo-2-methylpropionate (13.7 g, 70 mmol) was added and 
the solution was allowed to stir for 24 hours at room temperature. The reaction mixture was 
filtered and concentrated. The residue was diluted with 10% HCl solution and stirred 
overnight at room temperature. The organic layer was extracted with hexane and dried over 
anhydrous MgSO4. The solvent was removed under vacuum and the residual crude product 
was purified by column chromatography, with petroleum ether/ethyl acetate (9/1) as eluent, 
to yield a yellow solid (12.78 g, 65% yield). 
1
H NMR (400 MHz, CDCl3) δ (ppm) = 4.15 (t, 
J=7.1 Hz, 2H), 3.27 (t, J=7.4 Hz, 2H), 1.68 (s, 6H), 1.66-1.60 (m, 2H), 1.45-1.34 (m, 2H) 
1.23 (t, J=7.1 Hz, 3H), 0.91 (t, J=7.4 Hz, 3H) 
13
C NMR (151 MHz,CDCl3) δ (ppm)  221.44, 
172.98, 62.04, 56.04, 36.67, 30.05, 25.47, 22.17, 14.12, 13.70. MS (ESI): m/z = 281.07 m/z 
(Calculated 281.07 m/z for [M+H
+
]) 
Synthesis of S-(2-cyano-2-propyl)-O-ethyl xanthate (2) 




H NMR (400 
MHz, CDCl3) δ (ppm) = 4.74 (q, J=7.2 Hz, 2H), 1.75 (s, 6H), 1.52 (t, 7.2 Hz, 3H). 
Poly(N-vinylpyrrolidone) (PVP) synthesis: 
NVP (1667 mg, 15 mmol), AIBN (10 mg, 0.06 mmol), RAFT agent 2 (118 mg, 0.60 mmol) 
were added to a 50 mL pear-shape flask. The reaction flask was degassed with argon for 1 
hour and immersed in a 60 C oil bath for 5 hours. After 5 hours, 1 mL of DCM was added 
and left to stir for 30 minutes. The solution was precipitated into diethyl ether and 
centrifuged. The precipitate was re-dissolved in DCM, precipitated in diethyl ether and 
centrifuged again. The polymer product was dried under reduced pressure overnight at room 
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Polystyrene (PS) synthesis:  
Styrene (1562 mg, 15 mmol), ACHN (20 mg, 0.08 mmol), RAFT agent 1 (162 mg, 0.57 
mmol), and toluene (2.0 mL) were added to a 50 mL pear-shape flask. The reaction flask was 
degassed with argon for 1 hour and immersed in a 100 C oil bath for 24 hours. After 24 
hours the solution was precipitated into methanol and centrifuged. The precipitate was re-
dissolved in THF, precipitated in methanol and centrifuged again. The polymer product was 
dried under reduced pressure overnight at room temperature to yield the desired polymer 
product (922 mg, 59% yield, Mn = 2488, Đ = 1.14) 
Poly(methyl methacrylate) (PMMA) synthesis: 
Methyl methacrylate (700 mg, 7.0 mmol), AIBN (8.50 mg, 0.05 mmol), RAFT agent 1 (70 
mg, 0.26 mmol), and dioxane (1.5 mL) were added to a 20 mL pear shape flask. The reaction 
flask was degassed with argon for 1 hour and immersed in a 70 C oil bath for 10 hours. 
After 10 hours the solution was precipitated into diethyl ether and centrifuged. The 
precipitate was re-dissolved in DCM, precipitated in diethyl ether and centrifuged again. 
Finally the polymer was dried under reduced pressure overnight at room temperature to yield 
the desired polymer (416 mg, 59% yield, Mn = 3976, Đ = 1.18). 
Poly(methyl acrylate) (PMA) synthesis: 
Methyl acrylate (775 mg, 9.0 mmol,), AIBN (9.3mg, 0.06 mmol), RAFT agent 1 (77 mg,   
0.28 mmol), and dioxane (1.5 mL) were added to a 20 mL pear shape flask. The reaction 
flask was degassed with argon for 1 hour and immersed in a 70 C oil bath for 10 hours. 
After 10 hours the solution was precipitated into isopropanol and centrifuged. The precipitate 
was re-dissolved in dioxane, precipitated in isopropanol and centrifuged again. The polymer 
was dried under reduced pressure overnight at room temperature to yield the desired polymer 
product (205 mg, 27% yield, Mn = 3416, Đ = 1.16) 
Poly(styrene-co-maleic anhydride-block-styrene) (SMA-b-PS) synthesis:  
Macro-RAFT 1a (200 mg, 0.04 mmol), styrene (57 mg, 0.55 mmol) and AIBN (1.7 mg, 0.01 
mmol) were added to a 20 mL pear-shape flask. The reaction flask was degassed with argon 
for 1 hour and immersed in a 70 C oil bath for 24 hours. The polymer was isolated by 
precipitation form isopropanol twice and dried under reduced pressure overnight at room 
temperature to yield the desired polymer product 3a (42 mg, 21% yield, Mn = 5001, Đ = 
1.22) 
Stellenbosch University  https://scholar.sun.ac.za




(1)  Perrier, S.; Takolpuckdee, P. J. Polym. Sci. A Polym. Chem. 2005, 43, 5347. 
(2)  Moad, G.; Rizzardo, E.; Thang, S. H. Aust. J. Chem. 2005, 58, 379. 
(3)  Whittaker, M. R.; Goh, Y. K.; Gemici, H.; Legge, T. M.; Perrier, S.; Monteiro, M. J. 
Macromolecules 2006, 39, 9028. 
(4)  Xu, J.; He, J.; Fan, D.; Wang, X.; Yang, Y. Macromolecules 2006, 39, 8616. 
(5)  Roth, P. J.; Kessler, D.; Zentel, R.; Theato, P. Macromolecules 2008, 41, 8316. 
(6)  Llauro, M. F.; Loiseau, J.; Boisson, F.; Delolme, F.; Ladavière, C.; Claverie, J. J. 
Polym. Sci. A Polym. Chem. 2004, 42, 5439. 
(7)  Zelikin, A. N.; Such, G. K.; Postma, A.; Caruso, F. Biomacromolecules 2007, 8, 2950. 
(8)  Pound, G.; McLeary, J. B.; McKenzie, J. M.; Lange, R. F. M.; Klumperman, B. 
Macromolecules 2006, 39, 7796. 
(9)  Qiu, X. P.; Winnik, F. M. Macromol. Rapid Commun. 2006, 27, 1648. 
(10)  You, Y.-Z.; Oupický, D. Biomacromolecules 2007, 8, 98. 
(11)  Roling, I.; Schmarr, H. G.; Eisenreich, W.; Engel, K. H. J. Agric. Food Chem. 1998, 
46, 668. 
(12)  Pound, G.; McKenzie, J. M.; Lange, R. F. M.; Klumperman, B. Chem. Commun. 2008, 
3193.  
Stellenbosch University  https://scholar.sun.ac.za
Chapter 5: Hydrogel Synthesis and Characterisation 
 
55 
5 Chapter 5: Hydrogel Synthesis and Characterisation 
 
5.1 Introduction 
Hydrogels are three-dimensional networks formed by hydrophilic homopolymer or 
copolymer chains, crosslinked to form water-insoluble matrices.
1,2,3
 These polymers have a 
high affinity for water, but the physical and/or chemical crosslinks prevent the networks  
from dissolving in aqueous media. Water penetrates the interconnected polymer chain 
domains and causes swelling of the polymer networks, which results in the formation of 
hydrogels. Hydrogels have the ability to retain their shape in solution despite the fact that 
they imbibe excessive amounts of water, in some cases up to thousand times the dry weight 
of the polymeric matrix.
4,5
 Their thermodynamic compatibility with water results in soft, 
hydrated materials with a degree of elasticity very similar to natural tissue, which makes 
them appealing candidates for mimicking natural biological tissue.
6,7,8
 Since mechanical, 
solute permeability, elasticity, swelling, and hydrophilic/hydrophobic properties of a 
hydrogel can be tailored by choice of polymers and synthesis method, it is possible to create 
gels that fulfil the demands of biomaterials with physical integrity and network structure 
suitable to be used as wound covers, implant coatings or materials that mimic in vivo 
functionality.
9,10,11
 In the past few decades, numerous polymeric hydrogels have been 







various other biological systems.
19
   
The crosslinks between the polymeric chains are classified as either physical or chemical. 
Physically crosslinked hydrogels occur due to entanglements between dynamic 
macromolecules or by linkages held together by non-covalent interactions, e.g. hydrogen 
bonding, ionic and hydrophobic interaction between polymer chains.
20
 Chemical gels arise 
through the formation of covalent bonds between functionalized polymers.
21
 These gels are 
generally easier to modify and have greater mechanical properties compared to physical gels.  
The main drawback of the Vasalgel/RISUG hydrogel system as a potential male 
contraceptive is its reversibility. Procedural difficulties in the reversibility of these gels by 
flushing with DMSO or NaHCO3 solutions have been encountered in rats and monkeys.
22,23
 
Additional non-favourable squeezing and manipulation of the vas has been enforced on 
subjects to dislodge the gel from the vas to the ejaculatory duct, resulting in additional 
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swelling and bruising. Reversal has been proven difficult by injection of the solvents as a 
result of viscous solutions in the duct due to use of high molar mass polymers. To date, 
sterilisation reversal in a human subject has not been reported. As such, this shortcoming in 
reversibility leaves scope for improvement. Reversibility can effectively be improved by the 
formation of a hydrogel composed of linkages that can readily breakdown into soluble low 
molecular weight fragments by the addition of non-harmful additives. This will solve the 
reversibility problem hampering the current system. 
Formation of a hydrogel by combining aqueous solutions of sodium borate (borax) and 
poly(vinyl alcohol) (PVA), a polyol polymer, have been reported by Duel et al. more than 
half a century ago.
24
 Hydrogel crosslinking is achieved by the esterification between the 
borate ion in borax and the diol groups in PVA.
25
 Gelation of other hydroxyl polymers with 
borax includes poly(glyceryl methacrylate)
26
 and a few polysaccharides.
27,28,29
 These latter 
gels are not suitable for biomedical applications since gelation is only achieved at a pH above 
the pKa of the boric acid (pKa = 9), outside the range of physiological pH.  However, it has 
been shown that the crosslinking efficiency can be improved by the use of polymers 
containing functional groups containing phenyl boronic acid (BA), as the binding of BA to 
1,3 diols in PVA is entropically favoured over borax crosslinking.
30,31
 The phenyl substituent 
results in an enhancement of electron deficiency of the boron centre and reduces the pKa of 
the boronic acid. Thus, binding of BA to 1,3 diols in PVA via boronic ester formation can 
happen at relevant physiological pH. A single chain of boronic acid containing polymer can 
interact with multiple chains of PVA to effectively crosslink through reversible ester 
formation in aqueous medium.  
A novel glucose-responsive drug delivery system based on a polymer gel formed by 
crosslinking PBA-functionalized poly(N-vinylpyrolidone), p(NVP-co-PBA), and PVA was 
reported by Kitano et al.
32
 The hydrogel was developed as a glucose sensitive sensor. It was 
found that reversible exchange of boronate-diol crosslinks occurs in the presence of glucose, 
which results in a weakening of the gel and dissociation at high glucose concentrations. This 
approach provides a potential route for effective gel disruption under near-physiological 
conditions. It was also found that increasing the PVA molecular weight as well as increasing 
the polymer concentrations increased the viscosity of the system, and these parameters could 
be easily adjusted to control the rheological properties of the hydrogel system. 
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5.2 Gel formation of SMI-BA and PVA 
SMI-25BA (32 mg, 3.95 x 10
-5
 mol MI, Mn  ̴  15 000) was dissolved in 500 µL phosphate 
buffered saline (PBS) and PVA (7.6 mg, 17.3 x 10
-5
 mol OH, Mn ̴ 130 000, ̴  99% 
hydrolysed) was dissolved in 500 µL PBS, respectively. The SMI-BA solution was added to 
the PVA solution. A single chain of boronic acid containing polymer can interact with 
multiple chains of PVA to effectively crosslink. After mixing the viscosity gradually 
increased until gel formation occurred a few minutes later. Preliminary gels with various 
composition ranges of the SMI-BA and PVA for making the hydrogel was investigated in 
order to determine if gelation takes place for a wide variety of concentrations. The results are 
summarised in Table 5.1  
Table 5.1 Preliminary hydrogel formulations 
 Firm gel formation                O  Loose gel formation                No gel formation 
 
A variety of firm, loose and no gels were obtained from the above formulations. Gelation 
occurred for the majority of the formulations. However, SMI-BA gels experienced ineffective 
gelation with 0.3 wt% and 0.6 wt% PVA formulations. This is primarily due to the reduced 
molar ratios of PVA to the SMI-BA gels compared to the other formulations with increased 
wt% PVA. In some instances, the addition of an increased molar ratio of SMI-BA (6 wt%) to 
increase the crosslinks between the polymers was just enough to notice a slight increase in 
viscosity, and obtain a loose gel. 
The 6 wt% SMA and PVA (1.5 wt% - 2.5 wt%) composition ranges were chosen for further 
analysis since they consisted of highest concentrations functionalised polymer and managed 
to form firm gels with relatively quick gelation times (Table 5.1). Gelation times were 
determined with the tilt test, by mixing the two aqueous polymer solutions in a glass vial and 
continuously tilting the vial until the gel appears to have formed Figure 5.1 shows the 
formation of the gel. 
PVA (wt%)      SMI-15BA (wt%) SMI-25BA (wt%) 
 6.0 2.5 1.5 6.0 2.5 1.5 
2.5       
2.0       
1.5   O   O 
0.6  O   O O 
0.3 O   O O  
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The gelation times of SMI-15BA gels were more than 2 times longer than SMI-25BA gels 
with the same PVA content. The decrease in gelling times of SMI-25BA are as a result of 
increased crosslink density caused by the additional reactive BA groups along the polymer 
chain, leading to tighter network formation in a reduced amount of time. A general trend 
observed for both functionalised polymers was a decrease in gelling time with increased PVA 
composition (Figure 5.2). This is primarily due to the introduction of more available diol 
functional groups in the mixture to crosslink, network formation occurs more readily and 
viscosity increases more rapidly. 
 
PVA (wt %) SMI-BA (6 wt %) 
 SMI-15BA SMI-25BA 
2.5 101 sec 38 sec 
2.0 152 sec 60 sec 
1.5 270 sec 90 sec 
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Figure 5.2 Gelation times obtained through tilt test (n = 3, 37 °C, pH = 7.4) 
It has been shown in literature that an increase the PVA molecular weight and/or polymer 
concentration results in a viscosity increase of the solution, affecting both gelation times and 
rheological properties of the gels.
32
 Furthermore, the influence of pH on the gelation and 
mechanical properties of the boronate ester crosslinked gels was investigated by 
Chantasirichot et al.
33
 It was found that in an alkaline environment, the phenyl boronic acid 
groups can readily switch from an uncharged state to an ionic charged state, leading to 
increased activation towards the hydroxyl groups. The effect of this is faster onset of gelling, 
higher crosslink densities and harder gels. It was shown that the gel time can significantly be 
reduced from 35 minutes to 15 minutes by an increase in pH = 7.4 to pH = 9.4. Gelation 
varied from a couple of seconds to minutes. However, for the purpose of our gels it was only 
relevant to investigate the behaviour of the gels under physiological conditions. 
5.3 Swelling studies 
Swelling studies involve the detection of mass increase of a gel as a function of time caused 
by liquid absorption by the polymeric network submerged in a particular fluid. The physical 
and mechanical properties of gels are also dependant on the percentage fluid absorbed by the 
gel.  As such, knowledge about the swelling properties of gels is important to determine the 
potential application of the gel. The degree of swelling depends on many factors such as the 
nature of the polymer and solvent, polymer-solvent compatibility and degree of crosslinking. 
A gel will rapidly absorb liquid and continue to absorb until equilibrium is reached.
34
 An 
exponential trend is expected, which will level off once equilibrium has been achieved. This 




















wt % PVA 
SMI-15BA
SMI-25BA
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 × 100 
 
 
Mt – Mass of the swollen gel at time t 
Mo – Mass of the gel at time 0 
 
The water uptake of initially dry hydrogels in phosphate buffered saline (PBS, pH = 7.4) was 
followed gravimetrically by removal of the gel from liquid, dabbing it dry on filter paper and 
subsequently weighing it at certain time intervals. A graph of % swelling with time was 
constructed by taking the average measurements of 3 samples.   
 
Figure 5.3 Swelling studies of various SMI-BA and PVA compositions 
From the graph in Figure 5.3 it is evident that all the gels absorb water rapidly during an 
initial period of 200 minutes, and reach equilibrium within 300 - 400 minutes of immersion. 
The water absorbed by the hydrated network is quantitatively represented by the equilibrium 
water content (EWC), the ratio of weight of water in the hydrogel to the weight of the 
hydrogel at equilibrium hydration, expressed as a percentage. See Table 5.3 for swelling 




















SMA15 - 1.5 PVA
SMA15 - 2.0 PVA
SMA15 - 2.5 PVA
SMA25 - 1.5 PVA
SMA25 - 2.0 PVA
SMA25 - 2.5 PVA
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 × 100 
 
Ms – Mass of the swollen gel at equilibrium 
Mo – Mass of the gel at time 0 
 
Table 5.3 Summary of selected hydrogel swelling conditions 
 
The absorption of water was found to depend on the degree of crosslinking of the gels. The 
swelling ratios of the gels decrease with increasing boronic acid modification along the SMA 
polymer backbone, as much tighter networks are able to form for SMI-25BA polymers. In 
addition the unreacted ring-opened maleic anhydride groups on the polymer chain increase 
the hydrophilic nature of the gel, resulting in increased water uptake. As the concentration of 
PVA increased, there is a decrease in the swelling ratio. This is due to the higher viscosity 
during gelation, leading to smaller pores. Furthermore, chain flexibility decreases, resulting 
in reduced swelling capacity of the polymer.
35
 The values of % EWC of obtained hydrogels 
(84% - 93%) are greater than the percentage water content of living tissues in the human 
body (ca 60%).
36,37
 As such, SMA-BA hydrogels, crosslinked with PVA are sufficient for 
biological use. Once the injected gels have swollen they will conform to the shape of the vas 
deferens, anchoring itself to the longitudinal folds of the of the inner vas deferens wall. 














SMI-15BA-1.5 PVA 2.38 x 10
-5 17.3 x 10-5  3.75 1000 0.0501 0.7011 93 
SMI-15BA-2.0 PVA 2.38 x 10
-5 23.2 x 10-5   4.00 1000 0.0567 0.6105 91 
SMI-15BA-2.5 PVA 2.38 x 10
-5 29.0 x 10-5   4.25 1000 0.0575 0.5020 89 
SMI-25BA-1.5 PVA 3.95 x 10
-5 17.3 x 10-5 3.75 1000 0.0561 0.4201 87 
SMI-25BA-2.0 PVA 3.95 x 10
-5 23.2 x 10-5   4.00 1000 0.0590 0.4015 85 
SMI-25BA-2.5 PVA 3.95 x 10
-5 29.0 x 10-5   4.25 1000 0.0610 0.3805 84 
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5.4 Rheological characterisation 
5.4.1 Gelation time 
The storage (G') and loss moduli (G'') of SMI-15BA-1.5 PVA (as example) measured during 
an oscillatory time sweep test are shown in Figure 5.4 over time (min). The incidence of a gel 
point in rheological curves was defined according to the Chambon and Winter criterion by 
the crossover of the storage modulus (G’) and the loss modulus (G’’) congruent over a range 
of frequencies to a constant phase angle of 45.
38,39,40
 The gel point, occurred at 4.33 ± 0.11 
min. The gel point of SMI-15BA-2.0 PVA was determined as 2.36 ± 0.07 min. In situ 
gelation could not be performed on the other gel formulations due to the rapid gelling time.   
 




When subject to oscillatory stress sweep (Figure 5.5), the storage moduli (G’) were constant 
until the ultimate stress level was reached as evidenced by a sharp decrease in G’. This was 
done to determine the ranges in which G’ of swollen gels are constant when subjected to 
stress, which are regarded as the linear viscoelastic region (LVR) of the gels. While sample 
structure is maintained, G’ is constant; when the stress is too high, breakdown occurs and G’ 
decrease.
41,42
 Once the LVR is determined, a frequency sweep can be used to determine the 
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Figure 5.5 Linear viscoelastic region determination of A) SMI-15BA and B) SMI-25BA with different wt 
% PVA, obtained through oscillatory stress sweep (1 Hz, 37 °C) 
 
Constant G’ values ranged for various gel formulations. SMI-15BA gels ranged from (12.5 ± 
0.5) x 10
3
 to (20.5 ± 0.7) x 10
3
 Pa with ultimate stress levels from (0.5 ± 0.04) x 10
3
 Pa to 
(0.8 ± 0.08) x 10
3
 Pa. SMI-25BA gels ranged from (20.5 ± 0.8) x 10
3
 Pa to (50.5 ± 1.0) x 10
3
 
Pa with ultimate stress levels from (0.5 ± 0.04) x 10
3
 Pa to (4.0 ± 0.1) x 10
3
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Figure 5.6 Storage moduli of gels obtained through oscillatory stress sweep (n = 4) 
Increased storage moduli of type SMI-25BA gels can be ascribed to the increased crosslink 
density and polymer chain entanglement, thereby enhancing the gel stiffness. Priest et al. 
reported rheology measurements on PVA and phenyl boronic terminated PPO-PEO-PPO 




Frequency sweep was performed on gels with constant shear stress to determine the 
mechanical stiffness of the gels. The G’ of SMI-15BA (as example), subjected to frequency 
sweep at a constant shear stress (250 Pa), exhibits a plateau in the range of 1 – 80 Hz (Figure 
5.7). This is followed by a slight increase at higher frequencies (80 - 100 Hz). The loss 
modulus (G’’) is one or two magnitudes lower than G’ over all measured frequencies and 
characteristic for all equilibrium swollen gels of different gel formulations. 
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G′ (the elastic component) and G′′ (the viscous component) are independent of frequency in 
the low frequency range (1 – 80 Hz) studied. This finding confirms that the hydrogels are 
fully crosslinked and swollen at the time of the measurements.
44
 Furthermore, the value of G′ 
is one to two orders of magnitude larger than the value of G′′ indicating that the hydrogels 
remains intact and elastic during the entire experiment.
45
 The slight increase in G’ at higher 




It is also readily known in literature that glucose is able to diffuse through the polymer gel 
and exchange with the boronate-diol crosslink, resulting in dissociation of the gel.
32
 This 
might hamper the use of the hydrogel as a potential male contraceptive by diabetic men as 
they may reach higher glucose concentrations in their seminal fluid. It was however noted 
that glucose sensitivity towards phenyl boronic acid was only observed at high pH values.
46,47
 
To investigate this further, immersion of the hydrogels with lowest crosslinking densities, 
SMI-15BA-1.5PVA and SMI-15BA-2.0PVA in glucose mixtures of pH = 7.4 and pH = 9 
was carried out. These gels were specifically chosen for the study since they are more likely 
to dissociate than higher crosslinked gels.  
Normal seminal glucose levels in healthy men is estimated to be between 1.02 mmol/L – 5.70 
mmol/L i.e. 18 mg/dL – 102 mg/dL.
48
 The gels were immersed in concentrations within and 
outside the normal range glucose range at two different pH levels and data is summarised in 
Table 5.4. 
 
Table 5.4 Reversibility studies of gels in glucose 
 
The immersion of gels in normal and high glucose concentration solutions at both pH values 
resulted in no dissociation. It was however observed that swelling of the gels occurred at 
glucose concentrations of 1000 mg/dL at pH = 7.4. This swelling behaviour as a result of 
glucose addition to boronate-diol crosslinks have been extensively reported in literature.
49,50
 





pH = 7.4 pH = 9.0 pH = 7.4 pH = 9.0 
Normal 50 mg/dL Ok Ok Ok Ok 
High 100 mg/dL Ok Dissociate Ok Dissociate 
Abnormally high 1000 mg/dL Swell Dissociate Swell Dissociate 
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minutes at the concentrations of 100 mg/dL or higher. An increase in glucose concentration 
to 1000 mg/dL resulted in faster dissociation of the gels.  
At physiological pH, glucose fails to respond to the boronate ester crosslinked gels. This 
potentially means that diabetic men could potentially use the hydrogel for contraception 
purposes since no dissociation of the gel will occur under physiological pH conditions. As 
such, reversibility of the gel will have to rely on injection of a sugar solution at pH = 9 or 
higher. Injection of a NaHCO3 solution can also be incorporated to achieve reversibility by 
dissolution of the polymer.   
5.6 Conclusion 
In this study, a range of SMI-BA polymers were effectively crosslinked with poly(vinyl 
alcohol) (PVA) in phosphate buffered saline, resulting in reversible gels. Gels formed 
spontaneously at physiological conditions (37 ºC, pH = 7.4) by the boronate ester crosslinks, 
without the need for additional chemical reagents that might leave undesirable byproducts. 
The gels were immersed in buffered aqueous solution to investigate the ability of the gels to 
absorb fluid. The swelling results delivered promising results for biological application. The 
biocompatibility was further enhanced by the ability of the polymeric network to swell in 
water without the need of harmful solvents.  
Gel properties (gelation times and elastic moduli) were readily influenced by the crosslinking 
densities. For the SMI-BA-PVA hydrogels, the cross-link density predominantly depends on 
two factors: (1) the fraction of BA groups in the gel precursor i.e. extent of modification of 
SMI-BA and (2) the concentration of PVA added to the solution. Alteration of physical and 
mechanical properties can easily be accomplished by the variation of these two parameters, in 
an attempt to obtain the desired properties. Reversibility of the gels could not be achieved by 
the addition of high concentrations of glucose at pH = 7.4. However, easy and fast 
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5.7.1 General experimental details 
An AR-1500 Rheometer (TA Instruments Inc.) with 20 mm diameter standard steel parallel-
plate geometry was used for the characterization of all samples. Oscillatory time, stress and 
frequency sweep tests were employed.  
Time sweep monitored the in situ formation of gels (100 μL, n = 4) over 10 min (50 μm gap 
thickness) at constant strain (2%), temperature (37 °C) and frequency (1 Hz). Storage (G′) 
and loss moduli (G′′) were recorded over time.  
Gels (1000 μL, n = 4, 22 mm diameter, 2.0 mm thick) used in stress and frequency sweep 
tests were formed for 1 hour at 37 °C. The formed gels were individually immersed in PBS to 
swell to equilibrium (37 °C, overnight). To prevent slippage, the plate height was adjusted, 
starting from the original sample height and compressing the sample to reach a normal force 
of 30% compression. 
Stress sweep (G’ as a function of oscillatory stress) was performed by shearing the gels (1-
10,000 Pa) at constant frequency (1 Hz) and temperature (37 °C) until structure breakdown.  
Frequency sweep (G’ and G’’ as a function of oscillatory frequency) was performed at a 
constant shear stress (50% of the LVR) by varying frequency from 1 to 100 Hz, to determine 
the mechanical stiffness of the gels. 
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6 Chapter 6: Epilogue 
 
6.1 General conclusions 
This thesis focussed on the design of an improved polymeric hydrogel system for the 
potential use as a reversible male contraceptive in the vas deferens of the male. SMA has 
previously shown to be a potential polymer for this application, due to its attractive chemical 
and biological properties, easy availability and low cost. The proposed outcome was to 
synthesise an improved biocompatible hydrogel system with enhanced reversibility and 
optimised mechanical properties in an attempt to overcome the shortcomings of the current 
injectable SMA hydrogel systems. The main findings of this study are summarised in the 
current chapter and recommendations for future work are discussed. 
In Chapter 3, RAFT mediated polymerization was utilized for its ability to synthesize SMA 
copolymers of well-defined molar mass and low dispersity. In addition, two different post-
polymerisation modification approaches of SMA were investigated to achieve hydrogel 
formation. The first approach involved the successful chemical modification of the anhydride 
residues of the polymer using 3-aminophenylboronic acid (BA). All boronic acid 
functionalised polymers (SMI-BA) were successfully characterised by ATR-FTIR 
spectroscopy and the degree of modification was quantified using UV-vis spectroscopy. In 
the second approach it was found that the reduction of the thiocarbonyl thio end-groups of 
SMA resulted in side-reactions that prevented the intended disulphide formation.  
Chapter 4 presented a model study into the dimerisation of polymers structurally similar to 
SMA to gain insight into the unsuccessful disulphide formation of SMA in Chapter 3. It was 
shown that PVP and PS readily couple to form disulphides, while the PMA, PMMA and 
SMA polymer cyclise to a thiolactone end group formed via the backbiting reaction promoted 
by the stability of the 5-membered ring. The thiolactone ring formation in these polymers was 
confirmed by 
13
C NMR spectroscopy. It was demonstrated that disulphide formation between 
two polymeric chains is predominantly dependant on the nature of the penultimate and 
terminal monomer units next to thiocarbonyl thio group of various RAFT-made polymers. As 
such, this side reaction was overcome by the chain extension of the SMA macro-RAFT agent 
with four styrene units to prevent cyclisation and promote disulphide formation of the 
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polymer. The potential use of these systems as hydrogels was not investigated further due to 
time constraints. 
Chapter 5 describes the formation and characterisation of SMI-BA-PVA hydrogels. A range 
of SMI-BA polymers were effectively crosslinked with poly(vinyl alcohol) (PVA) in 
phosphate buffered saline, resulting in reversible gels. Gels formed spontaneously at 
physiological conditions (37 C, pH = 7.4) by the boronate ester crosslink formation. The 
swelling behaviour of the gels, immersed in buffered aqueous solution delivered promising 
results for biological application. Enhanced biocompatibility of the gels is achieved by the 
use of aqueous solutions as opposed to DMSO as a solvent in Vasalgel. The structural 
properties of the gels were characterized as a function of composition and degree of 
modification (SMI-BA) by oscillatory rheometry. For the SMI-BA-PVA hydrogels, the 
crosslink density predominantly depends on two factors: (1) the fraction of BA groups in the 
gel precursor i.e. extent of modification of SMI-BA and (2) the concentration of PVA added 
to the solution. It was found that the mechanical properties of the gels can easily be tuned by 
the variation of these two parameters, in an attempt to obtain gels with desired gelation times 
and elasticity. Adequate gelation times of approx. 1-5 minutes (37 C, PBS, pH = 7.4), with 
storage moduli (G’) 12 kPa – 50 kPa, were obtained. Rapid reversibility of the gels is 
achieved by the addition of glucose in combination with sodium carbonate (NaHCO3), to 
overcome the reversibility issues Vasalgel currently faces.  
6.2 Future recommendations 
 
These encouraging results suggest that the injectable hydrogels developed in this project have 
considerable potential as male contraceptive. However, further development of the system 
needs to be considered. 
Further research in terms of in vitro studies is required for the SMI-BA-PVA hydrogels 
developed so far in this study. This should be done in order to evaluate the efficacy of the 
hydrogel system as a contraceptive in the presence of spermatozoa. In addition, the motility 
and vitality of the sperm needs to be assessed. Furthermore, the stability of the hydrogel 
needs to be evaluated in order to establish if such a system will be able to achieve 
contraception over long periods of time (10 years) before any advancement towards in vivo 
studies can be carried out.    
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